Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Mar 11.
Published in final edited form as: Eur J Neurosci. 2022 Mar 14;56(9):5564–5586. doi: 10.1111/ejn.15636

From synapses to circuits and back: Bridging levels of understanding in animal models of Alzheimer’s disease

Udaysankar Chockanathan 1,2,3,4, Krishnan Padmanabhan 1,2,3,4,5,6
PMCID: PMC10926359  NIHMSID: NIHMS1956607  PMID: 35244297

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by behavioural changes that include memory loss and cognitive decline and is associated with the appearance of amyloid-β plaques and neurofibrillary tangles throughout the brain. Although aspects of the disease percolate across multiple levels of neuronal organization, from the cellular to the behavioural, it is increasingly clear that circuits are a critical junction between the cellular pathology and the behavioural phenotypes that bookend these levels of analyses. In this review, we discuss critical aspects of neural circuit research, beginning with synapses and progressing to network activity and how they influence our understanding of disease processed in AD.

Keywords: Alzheimer’s disease animal model, Computational models, Network activity, neural circuits

1 |. ALZHEIMER’S DISEASE: LEVELS OF ANALYSIS

Alzheimer’s disease (AD) is a neurodegenerative disorder that causes an array of cognitive and behavioural symptoms, including memory loss, impaired language function, visuospatial disorientation and social deficits (Greene et al., 1996; McKhann et al., 1984; Mega et al., 1996; Savva et al., 2009). Described by Alois Alzheimer at the start of the 20th century, the diagnosis of AD has relied largely on patient history, with progressive impairment in memory, language and executive function serving as the clinical hallmarks of the disease (McKhann et al., 1984, 2011). The search of the neurobiological origins of this cognitive decline has focused on the cellular and molecular basis of AD (Braak & Braak, 1991; Thal et al., 2002). Two histological hallmarks of pathology have emerged: amyloid plaques, extracellular aggregates of amyloid-β (Aβ), and neurofibrillary tangles, intracellular inclusions of aberrantly phosphorylated tau protein (Braak et al., 2011; Hardy & Higgins, 1992; Kosik et al., 1986; Mandelkow & Mandelkow, 1998; Selkoe, 1991).

Aβ is a misfolded protein formed from the metabolism of amyloid precursor protein (APP), a transmembrane protein concentrated in neuronal synapses (Masters et al., 1985). Aβ is generated due to the cleavage of APP by β-secretase and γ-secretase (Selkoe, 1994). In familial autosomal dominant forms of AD, the generation of Aβ is increased (Goate et al., 1991; Sherrington et al., 1995; Wolfe et al., 1999). In sporadic or late-onset AD, it is believed that Aβ clearance is decreased and that the propensity of Aβ, especially the Aβ42 species, to aggregate into oligomers, fibrils and plaques, is increased (Genin et al., 2011; Morris et al., 2010; Sanan et al., 1994; Selkoe, 2002). Aβ pathology occurs in both cortical regions as well as the medial temporal lobe and hippocampal formation, spreading to other regions in an anterograde manner (Thal et al., 2002; Thal, Rüb, et al., 2000).

Tau is a microtubule-associated protein in axons that regulate microtubule stability (Weingarten et al., 1975) and intracellular trafficking (Ram et al., 2008; Vershinin et al., 2007). In AD, tau loses its ability to bind to microtubules and undergoes an array of post-translational modifications, including hyperphosphorylation and glycosylation (Grundke-Iqbal, Iqbal, Tung, et al., 1986; Wang et al., 1996). These post-translational modifications, as well as the increased cytosolic concentration of tau present due to its diminished ability to bind to microtubules, allow for tau molecules to interact with one another and generate paired helical fragments, neurofibrillary tangles and other aggregates (Congdon & Sigurdsson, 2018; Grundke-Iqbal, Iqbal, Quinlan, et al., 1986; Kidd, 1963; Meraz-Ríos et al., 2010). Tau pathology, first appears in the transentorhinal region (Braak Stages I and II), expands to involve the hippocampus proper and other limbic areas (Braak Stages III and IV) and then spreads throughout the cortex (Braak Stages V and VI) (Braak et al., 2011; Braak & Braak, 1991). The degree of tau pathology has been found to correlate strongly with the cognitive impairment (Bancher et al., 1993; Brier et al., 2016; Giannakopoulos et al., 2003; Thal, Holzer, et al., 2000), possibly even more strongly than Aβ pathology, though this remains an area of active research. The spatio-temporal spread of tau pathology has four distinct trajectories, with each accounting for approximately 20–30% of cases (Vogel et al., 2021) and each of which may point to specific subnetworks within cortical and subcortical circuits that are vulnerable.

If one regards the study of AD across a continuous hierarchy of nervous system organization (molecular and cellular, synaptic and neuronal, circuits and behaviour), then the behaviours that typify patient presentation in AD and the cellular and molecular pathology associated with AD lie at two ends of this hierarchy (Figure 1a). Studies that start with behaviour have their origins in function, diving down to trace disease aetiology back to cellular and molecular pathology. By contrast, studies that begin with molecular and cellular pathology adopt a bottom-up strategy, ascending across levels of analyses to behaviour. Irrespective of the path taken, all approaches pass through the level of neural circuits, a critical junction between the molecular and behavioural approaches. We broadly define the circuit as the anatomical and physiological properties of individual neurons and the functional networks they form. As a number of methods exist for monitoring the structure and function of the circuit over time, an approach for investigation that originates at the circuit would be especially powerful in tracking changes in the architecture of the brain from early to mid to late stages of disease across each of these levels (Figure 1b). Thus, instead of seeing the circuit as a waypoint between two levels of analysis, we propose that beginning at the level of the circuit and working outward towards both behaviour and cellular and molecular pathology could provide critical insight into the aetiology of AD and shed light on the gaps in our understanding. For instance, why, in certain patients, does Aβ plaque burden fail to correlate strongly with cognitive impairment (Crystal et al., 1988; Katzman et al., 1988; Price & Morris, 1999; Tomlinson et al., 1968). Alternatively, why are certain emotional and cognitive domains diminished, whereas others are preserved in AD (Concepcion et al., 2015; Greene et al., 1996; McKhann et al., 2011; Mega et al., 1996; Merriam et al., 2018; Savva et al., 2009; Serby et al., 1991; Teri et al., 1999; Warner et al., 1986), even when patients appear to share similar hallmarks of disease pathology?

FIGURE 1.

FIGURE 1

(a) Schematic of space defined by the levels at which AD is studied, the brain areas within animal models where these experiments were performed and the models of pathology that were used to recapitulate disease processes. The cellular and molecular hallmarks of AD pathology and the behavioural profile of patients with AD are well known (green areas), whereas the impact of that pathology on synapses, circuits and population activity is the focus of this review (yellow areas). (b) An added dimension of study in AD is the changes in the brain across different levels of analysis, different brain areas and different models over time. (c, d) Experiments choose specific aspects of the space of inquiry to study, thereby carving out planes within the volume. For example, studies that look at the impact of different pathology models within a single brain area across molecular, synaptic and cellular levels (c) would be orthogonal to studies that examine the impact a single pathology model has across different brain areas on synaptic and neuronal properties

Studying AD from the perspective of neural circuits is more than just an alternative epistemological strategy. Consider, for example, the primary pharmacological interventions for AD, acetylcholinesterase inhibitors and N-methyl-d-aspartate (NMDA) receptor antagonists (Massoud & Léger, 2011). These medications can alleviate some of the behavioural symptoms of dementia in some patients but do not undo the cellular and molecular damage of AD or substantially alter the course of the disease (Howard et al., 2012; Kaduszkiewicz et al., 2005; Tariot et al., 2004). Conversely, experimental ‘disease-modifying therapies’, such as monoclonal antibodies against Aβ, which demonstrably reduce Aβ plaque burden (Farlow et al., 2012; Rinne et al., 2010; Siemers et al., 2010), have nonetheless had limited success in ameliorating cognitive function (Cummings et al., 2014; Doody et al., 2014; Salloway et al., 2014) (aducanumab, an Aβ-directed monoclonal antibody-targeted therapy, being a recent controversial exception [Musiek & Bennett, 2021; Sevigny et al., 2016]). Finally, alterations in neural circuits, such as changes in dendritic morphology and disruptions in synaptic plasticity, are well documented in the context of Aβ and tau pathology (Klyubin et al., 2005; Palop et al., 2007; Šišková et al., 2014; Wei et al., 2009; Yoshiyama et al., 2007). Drugs targeting Aβ or tau that may alleviate plaque burden or remove tangles may not fix the damage by that pathology done to the synapses and networks of neurons that underlie memory, cognition and behaviour. By contrast, recent approaches that target circuits appear to not only improve cognition but also decrease cellular pathology (Adaikkan et al., 2019; Iaccarino et al., 2016; Martorell et al., 2019).

In this review, we will explore the literature on the effects of Aβ and tau pathology through the lens of the neural circuit, starting with individual synapses and single neurons and ending with populations of cells. To understand how cellular pathology alters the circuit and, in turn, cognition and behaviour, we will review frameworks at each level of analysis that may provide critical insights into the neurobiology of AD. In this regard, it is useful to think of specific experiments as slices through this space of analysis whose dimensions are defined by the brain area being studied, the model being employed and the level of analysis with which the system is being interrogated. For example, a study that focuses on different models (APP/PS1 vs. 3xTg) within a single brain area, such as the cornu Ammonis subfield 1 (CA1) region of hippocampus (Figure 1c, top), would constitute a slice in this space orthogonal to a study that looks at a specific pathological model (APP/PS1) across two different brain areas (neocortex vs. hippocampus, Figure 1c, bottom). The goal of this review is to discuss how current experiments fill in the volume of understanding of AD across regions and animal models within the levels of analysis of the neural circuit.

2 |. SYNAPSES AND AD

Although Aβ plaques and tau tangles are the hallmarks of AD, changes in the structure and function of synapses appear to be more correlated with the cognitive decline observed in patients (Terry et al., 1991) and in animal models of the disease (Selkoe, 2002). This is perhaps expected, as synaptic connectivity forms the neural basis of learning and memory, and thus, disruptions in synaptic properties affect cognition. Over the last decade, a number of critical insights have been gained about the structure and function of synapses. When integrated with studies on synaptic damage in animal models of AD, such findings link cellular pathology with changes in neuronal activity.

On excitatory neurons in both cortex and hippocampus, dendrites are pockmarked with synapses whose structure and function provide critical insights into single-neuron computation. Excitatory synaptic connections are made on spines, small protuberances along the dendritic tree that vary in size and shape (Engert & Bonhoeffer, 1999; Hausser et al., 2000; Kasai et al., 2010; Yuste & Bonhoeffer, 2001; Zuo et al., 2005). Spine size appears to be related to synaptic strength (Arellano et al., 2007; O’Donnell et al., 2011), which, in turn, plays a critical role in memory and learning. Beginning with studies by Bliss and Lømo (1973), the use-dependent strengthening or weakening of synapses, referred to as long-term potentiation (LTP) and long-term depression (LTD), has provided a framework for connecting synaptic structure to functional plasticity (Madison et al., 1991). Bursts of high-frequency electrical stimuli in presynaptic populations resulted in persistent increases in the amplitude of excitatory post-synaptic potentials (EPSPs) between neurons. In subsequent studies, plasticity was induced by tightly coupling the timing of presynaptic and post-synaptic action potentials, so-called spike-time-dependent plasticity (STDP) (Bi & Poo, 1998; Markram et al., 1997; Sjöström & Nelson, 2002). Here, in order to induce synaptic plasticity, the post-synaptic neuron must fire precisely within a narrow interval following presynaptic spiking (Bi & Poo, 1998; Froemke & Dan, 2002). Interestingly, the rules governing how synapses are strengthened or weakened in STDP depend not only on the statistical properties of spiking (Froemke & Dan, 2002; Sjöström et al., 2001) but also on the location along the dendrite where the synapse is located (Froemke et al., 2005). LTP and STDP represent biological instantiations of Donald Hebb’s postulate on learning (Hebb, 1949). Importantly, rather than being singular, the rules for plasticity, and therefore learning, arise from a constellation of factors related to the structure of synapses and dendrites.

This diversity in synapse structure and function is critical for understanding the molecular and cellular hallmarks of AD, such as Aβ and tau pathology (Figure 2, left). Consequently, disruptions in synaptic function and the transmission of signals from one neuron to another are altered in different ways depending on the brain area and the synapse type. These effects occur both pre- and post-synaptically. For example, Aβ decreases presynaptic release probabilities (Abramov et al., 2009). On the post-synaptic side, it induces the internalization and removal of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and NMDA receptors (Hsieh et al., 2006; Palop et al., 2007; Snyder et al., 2005) as well as the inhibition of paired-pulse facilitation and LTP (Chapman et al., 1999; Palop et al., 2007; Wei et al., 2009). These disruptions to synaptic plasticity, specifically LTP, have been replicated when human Aβ oligomers were injected into rodent hippocampus (Klyubin et al., 2005; Shankar et al., 2008). Furthermore, in hippocampal slices from APP/PS1 mice, Aβ alters in the temporal windows required for STDP (Garad et al., 2021), suggesting that the precise plasticity rules associated with STDP may be subject to amyloid pathology. This inhibition of LTP by Aβ may be mediated by the glycogen synthase kinase-3β (GSK-3β) signalling pathway, wherein the dephosphorylation of the key synaptic scaf-folding protein post-synaptic density protein 95 (PSD-95) leads to removal of AMPA receptors, though many other mechanisms have also been proposed (Guntupalli et al., 2016; Jo et al., 2011; Kim et al., 2007; Nelson et al., 2013). Similar disruptions to synaptic function and LTP, as well as synaptic loss, have been reported in the context of tau pathology (Biundo et al., 2018; Di et al., 2016; Fá et al., 2016; Hoover et al., 2010; Lasagna-Reeves et al., 2011; Sydow et al., 2011). Though the molecular mechanisms that underlie this synaptic dysfunction are still being uncovered (Regan et al., 2017), a recent study showed that certain phosphorylated tau species may act through the protein kinase C and casein kinase substrate in neurons protein 1 (PACSIN1) to disrupt AMPA receptor trafficking (Regan et al., 2021). It should be noted, however, that the mechanisms by which Aβ and tau modulate synaptic transmission, as well as the synergistic impact of these two pathologies, are complex and continue to be an area of active investigation (Crimins et al., 2013; Manczak & Reddy, 2013; Palop & Mucke, 2010, 2016; Puzzo et al., 2017; Shipton et al., 2011).

FIGURE 2.

FIGURE 2

Effects of Aβ pathology across multiple features of the circuit in the APP/PS1 mouse model. (Left) APP/PS1 mice have truncated dendritic trees, deficits in LTP induction, degraded receptive fields and deficits in learning and memory. (Right) Network analysis of the circuit level changes in APP/PS1 animals reveals that functional connectivity is reduced as measured by correlated activity. This leads to a reduction in the combinatorial patterns generated by populations of neurons in APP/PS1 animals in CA1. The reduction in combinatorial patterns could lead to either representations being lost (the loss of patterns corresponding to features in the sensory world or episodes of memory) or degenerated (patterns come to represent multiple features or episodes of memory). Both types of changes in neural representations make specific predictions about how learning and memory are impacted in APP/PS1 animals

These results point to the critical role Aβ and tau pathology play in synaptic organization and function (Fitzjohn et al., 2010; Gengler et al., 2010; Gureviciene et al., 2004), but they also raise important questions. In some cases, Aβ pathology alters the induction of LTP in older mice (Gengler et al., 2010), suggesting that the mechanisms associated with the initial stages of plasticity are impacted in AD. In other examples, the effect seems to be on the decay kinetics of LTP (Gureviciene et al., 2004), suggesting that the effect of Aβ pathology is on the maintenance of recent plasticity events in which synaptic strengths were altered. Under what conditions the effects of AD pathology influence the initiation and maintenance of synaptic plasticity, and the extent to which these effects vary in cortical vs. hippocampal circuits remains an open question.

All findings of the effects of AD pathology on synapses are largely agnostic to the sites of that plasticity along the dendrites. As the location of a synapse on a dendrite affects how the relative timing of pre- and post-synaptic spikes will either strengthen or weaken it (Froemke et al., 2005), changes in the morphology and location of spines seen in Aβ animal models (SantaCruz et al., 2005; Šišková et al., 2014; Tsai et al., 2004; Yoshiyama et al., 2007) warrant further exploration of the parameters of STDP as they pertain to AD. The impact of AD pathology may therefore be contingent not only on how it disrupts synaptic learning but also on the precise location of that pathology on the dendritic tree.

3 |. NEURONS AND AD

Over a century ago, Santiago Ramón y Cajal drawings revealed the immense anatomical diversity of individual neurons (y Cajal, 1911). In later studies, computational models showed how these different cellular architectures, particularly the morphological variations in the dendritic tree, shape the pattern of neuronal firing (adapting, non-adapting and bursting) (Mainen & Sejnowski, 1996). In addition, the particular complement of ion channels carried by different neurons further shapes their biophysics (Gjorgjieva et al., 2016; Padmanabhan & Urban, 2010; Schulz et al., 2006).

The association between Aβ pathology and dysmorphic neurons is well documented. Studies of transgenic mouse lines that overexpress mutant isoforms of APP have shown decreased synapse density, ectopic axon sprouting, thickened boutons and degradation of dendritic spines (Hsia et al., 1999; Phinney et al., 1999; Tsai et al., 2004). Confocal microscopy studies of post-mortem brain tissue from APP mouse models (Figure 2, left) as well as from human patients with AD, showed that the dendrites inside an Aβ plaque were narrower and had a higher curvature than those outside the plaques (Knowles et al., 1999). Though some studies have reported overt neuronal loss in APP mouse models (Hsia et al., 1999), paralleling what has been observed in humans (Gómez-Isla et al., 1997; Vogt et al., 1992; West et al., 1994), others have shown conflicting results (Irizarry et al., 1997). Similar morphological changes have been reported in the context of tau pathology, especially when the tau aggregates into intraneuronal tangles. For example, a study of post-mortem brain tissue from patients with AD showed that neurons that contained neurofibrillary tangles had fewer dendritic spines and more dendritic atrophy than other neurons from the same patients that did not contain tangles (Merino-Serrais et al., 2013; Mijalkov et al., 2021). Synapse loss and brain atrophy have also been reported in mouse models of tauopathy, sometimes even before the accumulation of tangles (SantaCruz et al., 2005; Yoshiyama et al., 2007).

These morphological changes likely have functional consequences for the biophysical properties of neurons. One study found that the increased firing rate of CA1 pyramidal neurons in the APP/PS1 mouse model could be explained by their altered dendritic morphology (decreased branching, surface area and length) and increased intrinsic excitability (Šišková et al., 2014), both features of the neuron itself rather than the synaptic inputs it receives. The evidence for the role of tau pathology in altering these intrinsic neuronal properties is less consistent. For instance, in the p301L R5 transgenic mouse model of tauopathy, in which neurons express a mutant form of tau associated with hereditary frontotemporal dementia (Deters et al., 2008; Götz et al., 2001), similar morphological changes, such as decreased dendritic length and branching, were observed (Müller-Thomsen et al., 2020). At the biophysical level, however, this study and others in tauopathy models found decreased intrinsic excitability of neurons (Hatch et al., 2017). Further research, especially on the potential differential impact of tau on different segments of the neuron (axon, dendrite and soma) (Hatch et al., 2017) and on the interaction between Aβ and tau (Hall et al., 2015), is necessary to elucidate properties of neurons that predict which intrinsic biophysical properties and what morphological elements are disrupted in AD (Cloyd et al., 2021). The initial conditions of the neuron’s identity, including the brain area it originated from, are thus paramount.

Synaptic damage, decreased dendritic branching and altered neuronal excitability in mouse models of Aβ and tau pathology (Hatch et al., 2017; Müller-Thomsen et al., 2020; SantaCruz et al., 2005; Šišková et al., 2014; Tsai et al., 2004; Yoshiyama et al., 2007) raise questions of how such changes affect the computations performed on the dendritic tree, an effective circuit within the single neuron. Previous studies have shown that synaptic inputs and the post-synaptic processing of those inputs vary along the dendritic tree (Dudman et al., 2007; Froemke et al., 2005; Johnston & Wu, 1994; Larkum et al., 1999; Svoboda et al., 1999). How does the reduction in dendritic branching observed in Aβ models (Šišková et al., 2014) affect the proximal inputs, as opposed to the distal ones? One possibility is that distal synapses are simply lost and the presynaptic cells that formerly provided inputs to the neuron no longer do so. Another possibility is that the distal inputs are remapped to more proximal sites along the dendritic tree, perhaps as a compensatory mechanism. If this latter scenario was true, how would this remodelling affect the computations performed by that neuron and the circuit more broadly? Addressing these issues could resolve outstanding mechanistic questions that link changes in dendritic morphology with alterations in both single-neuron and network activity. For instance, morphology-specific pathology could reflect the pathway-specific disruptions in neuronal activity that depend on the activity of presynaptic populations (Cash & Yuste, 1999; Hausser et al., 2001; Larkum et al., 1999; Magee, 2000). Finally, what is the interplay between homeostatic plasticity that affects features such as neuronal excitability and synaptic plasticity in AD models (Hengen et al., 2013; Turrigiano, 2008; Turrigiano et al., 1998)?

Synaptic input, dendritic integration and neural excitability are cellular descriptors that define what causes a neuron to spike. From another perspective, what causes a neuron to spike can also be defined from the perspective of systems neuroscience perspective as the set of stimuli or behaviours that generate action potentials: the neuron’s receptive field, the region of stimulus space that is best suited to evoke a neuronal response (Hartline, 1938; Hubel & Wiesel, 1962; Sherrington, 1952). Receptive fields have been observed across multiple primary sensory modalities (Hubel & Wiesel, 1962; Knudsen & Konishi, 1978) as well as in higher order neural representations (Aronov et al., 2017; Hafting et al., 2005; Okuyama et al., 2016). Recent evidence, however, suggests that individual dendritic spines or dendritic segments on that neuron respond to features that are distinct from what drives the soma (Chen et al., 2011; Jia et al., 2010; Scholl et al., 2021; Varga et al., 2011; Wilson et al., 2018), making that answer far from simple; what drives the spine appears to be different than what drives the neuron. Some studies have shown that synapses with similar receptive fields are spatially clustered on the dendritic tree (Scholl et al., 2017) and that such clustering may help enhance the feature selectivity of neurons (Wilson et al., 2016). A consequence of this functional variation among synapses is that neurons often have subthreshold responses far more complex and diverse than can be gleamed from only looking at spiking activity (Harvey et al., 2009; Poirazi et al., 2003; Schummers et al., 2002; Volgushev et al., 2000). Seen through the lens of AD pathology, questions about what causes a spine to depolarize and what causes a neuron to spike become particularly pressing. For example, changes in the ratio of synapses tuned to the preferred stimulus of the soma and those tuned to non-preferred stimuli, as well as alterations in intrinsic excitability and morphology (Šišková et al., 2014), are all likely to degrade the information encoding abilities of neurons (Cacucci et al., 2008; Cayzac et al., 2015; Grienberger et al., 2012), but which feature contribute to what types of information loss remain unknown.

Studies of changes in the information content of neuronal spiking patterns in AD have largely focused on the hippocampus, especially place cells (Figure 2, left). These are neurons that preferentially increase their firing rate when an animal visits a particular region of its environment, denoted as its place field (O’Keefe & Dostrovsky, 1971; O’Keefe & Nadel, 1978). Multiple studies have shown that place fields are larger, less stable from trial to trial, and less informative about an animal’s location in mouse models of Aβ or tau pathology than in age-matched non-transgenic mice (Cacucci et al., 2008; Cayzac et al., 2015; Cheng & Ji, 2013; Jun et al., 2020; Mably et al., 2017). Moreover, one such study reported that the degree of place field degradation in a given animal was proportional to its Aβ plaque load (Cacucci et al., 2008). These neural coding disruptions extend beyond the hippocampus. For example, although orientation and direction tuning in primary visual cortex neurons were diminished with age in non-transgenic mice, the magnitude of this degradation in tuning was significantly worse in APP23/PS45 mice, relative to age-matched controls (Grienberger et al., 2012). Linking these changes in the neuron’s receptive field back to the changes in the synapse and the dendrite will help illuminate how and why pathology complicates the story of what causes a neuron to spike.

4 |. ENSEMBLE CODING AND ACTIVITY IN AD

Studying the response properties of single neurons can provide some insight into the impact of AD on information coding in the brain (Cacucci et al., 2008; Cayzac et al., 2015; Grienberger et al., 2012). However, individual neurons function as part of a larger network, and it is the coordinated activity of populations of neurons that ultimately shapes perception, behaviour and cognition. It is thus critical to understand the effect of AD pathology on neural circuits and ensembles, which are defined as groups of neurons critical for carrying and representing information within a brain region.

First, even within a single brain area, individual neuronal responses vary across complex stimuli (Okuyama et al., 2016; Quiroga et al., 2005) and different neurons exhibit different kinds of variation to stimuli. It is the response diversity, both across stimuli in a single neuron and across neurons to a single stimulus, that is a necessary prerequisite for the brain to encode the enormous space of possible sensory stimuli (Barlow, 1972). The study of how neurons encode information, be it the way a population of neurons in the cortex represents visual sensory inputs via patterns of activity, or the way in which groups of cells in the hippocampus encode an animal’s position in space or a memory, is a major area of research in systems neuroscience. Consider, for example, the place cells of the CA1 region of the hippocampus (O’Keefe & Dostrovsky, 1971; O’Keefe & Recce, 1993; Skaggs et al., 1993; Wilson & McNaughton, 1993). Place cells are diverse, varying in location and size; neurons in ventral CA1 have place fields that are larger and less informative about the animal’s position than those in dorsal CA1 (Chockanathan & Padmanabhan, 2021; Jung et al., 1994; Keinath et al., 2014; Kjelstrup et al., 2008). Collectively, the ensemble of place cells ‘tile’ the animal’s environment, with the place field of each neuron covering a certain portion of the space. It is thus believed that place cells constitute a key component of the brain’s internal map of the world (McNaughton et al., 2006; O’Keefe & Dostrovsky, 1971). Ensemble representations of place are more stable and robust than single-neuron representations (Meshulam et al., 2017; Ziv et al., 2013). Thus, the animal’s position is defined by the state of the population, patterns of activity that are constrained by the correlations between neurons, including place and non-place cells (Meshulam et al., 2017; Stefanini et al., 2020). Each neuron’s representation is therefore not an island, but part of a larger system, whose structure is determined by the interplay of inputs to the population of neurons and the connections they form with one another. Further evidence for the population code comes from other studies that show that multiple place codes can exist for a single environment and that the population can spontaneously remap from one place to another over the course of months (Low et al., 2021; Sheintuch et al., 2020; Ziv et al., 2013). To decode the position of the animal in such a dynamic and distributed coding scheme, the activity of any individual place cell must be considered in the context of the other neurons in the population.

Hebb (1949) proposed that these ‘cell assemblies’, groups of neurons that repeatedly coactivated, could form the neural substrate for a sensory percept or a memory. Hopfield (1982) developed this idea in a network model, revealing how memory stability, pattern completion and error correction could arise emergently from the dynamics of these assemblies. Over the past decade, technological advancements have enabled the recording and manipulation of large neuronal population, thus allowing these frameworks to be explored experimentally. For example, the technique of two-photon microscopy coupled with holographic optogenetic stimulation (Packer et al., 2015; Rickgauer et al., 2014) allows for specific subpopulations of neurons to be coactivated with high spatio-temporal precision while simultaneously imaging all the activity of a large population of neurons. In these experiments, stimulating subsets of cells is sufficient to repeatedly recruit and activate larger ensembles of neurons, illustrating the interconnectedness of the component cells that cortical ensembles (Carrillo-Reid et al., 2016, 2019). These findings are not limited to the visual system; optogenetic stimulation experiments in the prefrontal cortex and hippocampus have shown the presence of ensembles that code for location, conspecific identity and fear (Kitamura et al., 2017; Liu et al., 2012; Okuyama et al., 2016; Steve et al., 2013), multiple lines of evidence that illustrate the criticality of populations of neurons in determining perception and behaviour.

An essential component of the level of analysis between the single neuron (in an APP/PS1 animal model for instance [Cacucci et al., 2008; Cayzac et al., 2015; Grienberger et al., 2012]) and behaviour in AD is the activity of the population. In vivo studies using two-photon imaging of calcium transients in multiple mouse models of Aβ pathology, including the APP/PS1 model, found populations of both hyperactive and hypoactive neurons in frontal cortex, with hyperactive neurons clustered near plaques, whereas hypoactive neurons were distributed more uniformly (Busche et al., 2008). Follow-up studies showed complex changes in neuronal activity in visual cortex (Grienberger et al., 2012) and dorsal CA1 hippocampus (Busche et al., 2012). In the former, significant changes in activity occurred even before the deposition of Aβ plaques. By contrast, experiments performed in the context of tau pathology revealed drastically different results. In the rTg4510 mouse model, which expresses a form of human tau (P301L) containing a mutation associated with frontotemporal dementia and parkinsonism, high levels of tau pathology were observed in the fore-brain (Ramsden et al., 2005). In this model, widespread suppression of neuronal activity was observed (Busche et al., 2019). Furthermore, in mice harbouring APP/PS1 mutations for Aβ pathology as well P301L mutations for tauopathy, the network activity was silenced, similar to the result observed in the rTg4510 model (Busche et al., 2019). These results suggest that, at the level of neuronal populations, the effects of tau may dominate those of Aβ, though more research is needed to elucidate the mechanisms by which these pathologies interact and the resulting alterations in network activity.

In the hippocampus, a study of population coding in the rTg4510 mouse model of tauopathy found that although the spatial information of individual place cells was decreased relative to non-transgenic controls, as had been reported in mouse models of Aβ pathology (Cacucci et al., 2008; Cayzac et al., 2015), ordered sequences of place cell activation were preserved (Cheng & Ji, 2013). Even though hippocampal neurons in the rTg4510 model failed to fire at the same position of the environment in each trial run, ensembles of neurons still activated in a replicable sequence, similar to the manner in which ensembles of place cells sequentially activate when an animal explores its environment. This suggests that the mechanisms that functionally bind groups of individual neurons into recurring ensembles are intact in the rTg4510 model. Interestingly, however, features of population activity tend to be weakened in other models of Aβ and tau pathology. In an electrophysiological study of large dorsal CA1 populations in awake mice, correlations between neurons were diminished in the APP/PS1 mice, relative to the controls, and this produced a reduction in the diversity of patterns generated by populations of neurons (Chockanathan et al., 2020). Reduction in the diversity of patterns or ensembles reveals that the neural ‘vocabulary’ available to populations of neurons is truncated in an Aβ model (Figure 2, right). That different studies find different effects of AD pathology on population coding is not surprising. For example, differences between Cheng and Ji (2013) and Chockanathan et al. (2020) may evidence the heterogeneous effects of pathology in balancing the influence of external stimuli (the position of the animal) and internal states and structures (the correlations between neurons) (Meshulam et al., 2017). AD pathology may decouple features of intrinsically generated hippocampal activity from external sensory inputs (Cacucci et al., 2008; Cayzac et al., 2015; Grienberger et al., 2012), thereby increasing the impact of local networks within the hippocampus on structuring activity. Additionally, changes observed at the network level at a single point in the late stages of Aβ pathology likely reflect the accumulated impact of many changes in the circuit over the progression of the disease. For example, aberrantly excitatory neural circuits in mouse models of amyloidosis show compensatory remodelling of inhibitory circuits (Palop et al., 2007), and studies that track changes in population activity over time will provide critical insights into how pathology ushers network activity into different states over the course of the disease.

These studies of population coding in the context of Aβ pathology have mostly employed transgenic models, such as the APP/PS1 line (Jankowsky et al., 2001). The advantage of these models is that they show robust plaque expression in the cortex and hippocampus (Whitesell et al., 2018), as seen in humans with AD (Thal et al., 2002; Thal, Rüb, et al., 2000). However, in addition to increasing Aβ pathology, such models also present potential confounds resulting from the insertion of the transgene and the overexpression of protein, including destruction of endogenous genes, overproduction of APP-associated species other than Aβ and non-specific endoplasmic reticulum stress (Barbero-Camps et al., 2014; Saito et al., 2014, 2016; Sasaguri et al., 2017). Knock-in mice present a way of modelling Aβ pathology while limiting these confounding effects (Drummond & Wisniewski, 2017; Saito et al., 2014). One widespread model is the APPNL-G-F strain (Saito et al., 2014). Encouragingly, recent studies that employed this model have replicated some of the key earlier findings from transgenic lines, such as spatial memory impairments (Saito et al., 2014), LTP deficits (Latif-Hernandez et al., 2020), decreased spatial information of place cells (Jun et al., 2020) and hyperactivity of neurons that are near sites of Aβ accumulation (Takamura et al., 2021). These studies naturally raise questions about how single-neuron and synaptic disruptions in these AD models may influence population and network activity.

5 |. OSCILLATORY ACTIVITY AND AD

These mesoscopic measures of circuit structure and function, as well as their disruptions in AD, reflect global patterns of activity throughout the brain. Methods such as electroencephalogram (EEG) and functional magnetic resonance imaging (MRI) that study the organization of brain activity at these scales in patients have provided the closest links to the mesoscopic activity of circuits. A critical link between measures of neural population activity in humans and those in animal models is the oscillations in the local field potential (LFP). LFP oscillations have been shown to play critical roles in spatial processing, temporal synchronization of spiking activity and memory consolidation (Dupret et al., 2010; Foster & Wilson, 2007; Jadhav et al., 2012; O’Keefe & Recce, 1993; Skaggs et al., 1996). Three frequencies in the LFP have a particular relevance to AD: theta oscillations, gamma oscillations, and sharp waves and ripples (SWRs).

Theta waves are 6–12 Hz oscillations found most strongly in the hippocampus (Vanderwolf, 1969). Several lines of evidence implicate theta oscillations in spatial coding. First, in both animal models and humans, the frequency and power of theta oscillations have been shown to increase during locomotion and active exploration and decrease during periods of immobility (Vanderwolf, 1969; McFarland et al., 1975; Rivas et al., 1996; M. Aghajan et al., 2017). Second, during exploration of an environment, place cells fire in a stereotyped manner with respect to the phase of the local theta oscillation (Harvey et al., 2009; O’Keefe & Recce, 1993; Skaggs et al., 1996). Namely, a place cell will fire action potentials at progressively more advanced phases of the theta oscillation as an animal traverses that neuron’s place field. This phenomenon, known as phase precession, offers numerous computational benefits, from increasing the precision of the cognitive map to addressing ambiguities that arise from different trajectories through the same location (Mehta et al., 1997, 2002). In populations, which are activated as an animal explores its environment, phase precession temporally orchestrates the firing of place cell into repeated sequences that occur on the time scale of STDP (Bi & Poo, 1998); even though an animal may take several seconds to traverse multiple place fields, theta-orchestrated place cell sequences could occur within tens of milliseconds. This offers a potential mechanism to strengthen the synaptic connections between the place cells involved and, in turn, increases the reliability of the hippocampal spatial code through population-level representations of space (Meshulam et al., 2017; Stefanini et al., 2020). The strengthening of these sequences may also facilitate memory consolidation during SWRs, as well as replay and preplay events.

Gamma oscillations are 30–100 Hz fluctuations in the hippocampus and cortex that manifest in a range of behavioural contexts, from sensory stimulation to selective attention to active exploration (Bragin et al., 1995; Fries et al., 2001; Gray et al., 1989; Pesaran et al., 2002). Several studies have linked the generation of gamma rhythms to inhibitory interneurons in the hippocampus (Bartos et al., 2007; Bragin et al., 1995; Cobb et al., 1995; Hájos et al., 2004; Lytton & Sejnowski, 1991; Whittington et al., 1995). In particular, slow gamma oscillations (25–50 Hz) arise from networks of fast-spiking parvalbumin (PV) interneurons (Buzsáki & Vanderwolf, 1983; Cardin et al., 2009; Carlén et al., 2012; Fries, 2009; Sohal et al., 2009; Traub et al., 1996). These oscillations are important for synchronizing neural activity from different parts of the brain (Engel et al., 1991; Gray, 1994; Gray et al., 1989), whereas fast gamma oscillations (50–100 Hz) facilitate communication between entorhinal cortex and hippocampus to allow for the encoding of new sensory information into memories (Bieri et al., 2014; Zheng, Bieri, Hsiao, & Colgin, 2016; Zheng, Bieri, Hwaun, & Colgin, 2016).

Finally, the SWR is a large-amplitude high-frequency (approximately 200 Hz) oscillation observed during immobility, eating, drinking and slow-wave sleep (Buzsáki, 1986; O’Keefe & Nadel, 1978; Vanderwolf, 1969). In SWRs that occurred during rest periods, it was found that ensembles of place cells rapidly reactivate. The temporal compression of these ‘replay’ and ‘preplay’ events, which occur on the order of hundreds of milliseconds (Diba & Buzsáki, 2007; Foster & Wilson, 2006), has led some to posit that their purpose is to strengthen the synaptic connections between the involved neurons by STDP (Bi & Poo, 1998), thereby facilitating learning and memory (Dragoi & Tonegawa, 2011; Dupret et al., 2010; Gillespie et al., 2021; Girardeau & Zugaro, 2011; Heller & Bagot, 2020; Jadhav et al., 2012; Ji & Wilson, 2006; Joo & Frank, 2018; Maingret et al., 2016; Pfeiffer & Foster, 2013).

Mouse models of Aβ and tau pathology also show disruptions in the LFP, including theta and gamma oscillations as well as SWRs. In the APP/PS1 mouse model, both theta power and theta frequency were reduced, relative to age-matched non-transgenic mice, even though average running velocity was higher in the APP/PS1 group (Cayzac et al., 2015; Scott et al., 2012). Though the explicit impact of this weakened theta oscillation on phase precession has yet to be extensively studied, the relationship between the theta phase and rhythmic spiking activity in place cells is weakened in the 3xTg mouse model of Aβ and tau pathology (Mably et al., 2017). Decrease oscillatory synchrony likely erodes sequences of activation (phase precession), as well as plasticity during those windows, possibly compounded by deficits in STDP and induction of LTP in APP/PS1 hippocampal neurons, particularly when the neuron is near an Aβ plaque (Garad et al., 2021). The net effect of these changes may be the poor spatial memory and decreased place cell information content in mouse models of Aβ pathology (Figure 2, left), as well as the recent finding that place cells in APP knock-in mice fail to remap between different environments (Cacucci et al., 2008; Cayzac et al., 2015; Jun et al., 2020).

Decreased power in the slow gamma frequency band has been observed in mouse models of tauopathy (Booth et al., 2016; Mably et al., 2017) and Aβ pathology (Goutagny et al., 2013; Iaccarino et al., 2016) as well as in the ApoE4 knock-in model of late-onset AD (Gillespie et al., 2016). In many of these studies, the deficits in gamma oscillations do not occur in isolation but rather manifest as decreased coupling between theta oscillations and gamma bursts (Booth et al., 2016) or decreased SWR-triggered gamma oscillations (Iaccarino et al., 2016). Consistent with the hypothesis that fast gamma rhythms are involved in encoding of new memories, whereas slow gamma rhythms are involved in retrieval of previously stored memories (Mably & Colgin, 2018), one recent study showed that APP/PS1 mice have a deficit in the retrieval, rather than storage or encoding, of memories (Roy et al., 2016). Researchers were able to rescue the deficit in contextual fear conditioning seen in APP/PS1 mice by optogenetically reactivating the ensembles of neurons that were initially activated in a particular context. This result implied that even though recall of that memory was impaired, the neural substrate of the memory was still present in the brain. In multiple mouse models of AD, GABAergic interneuron dysfunction has been observed (Kurudenkandy et al., 2014; Leung et al., 2012), presenting a possible mechanism for disrupted slow gamma rhythms. Moreover, optogenetic stimulation of PV interneurons with a 40 Hz entrainment signal can not only restore slow gamma oscillations but also reduce Aβ pathology in 5XFAD mice (Iaccarino et al., 2016). Encouragingly, follow-up studies have suggested that non-invasive audiovisual sensory stimulation at 40 Hz can also restore slow gamma oscillations throughout the brain, reduce tau and Aβ pathology, and improve cognition in multiple mouse models (Adaikkan et al., 2019; Iaccarino et al., 2016; Martorell et al., 2019).

Many studies have shown a reduction in the amplitude, intensity, occurrence and frequency of hippocampal SWRs in mouse models of Aβ and tau pathology (Ciupek et al., 2015; Gillespie et al., 2016; Jones et al., 2019; Jura et al., 2019; Nicole et al., 2016). One study of the apoE4 mouse model, which expresses a major genetic risk factor in sporadic human AD, showed not only that SWRs were sparser in transgenic mice than the controls but also that future impairments in learning were correlated with the abundance of SWRs (Jones et al., 2019). A recent study in 5XFAD mice revealed that SWRs occur less frequently and with a shorter duration relative to wild-type controls (Prince et al., 2021). Furthermore, although place cells were less likely to be reactivated during SWRs, the activity of place cells during active exploratory behaviour was similar between the two groups, suggesting that the features of the LFP and ensemble activity may be damaged in AD even in the absence of changes to single-neuron tuning properties (Prince et al., 2021). Decreased occurrence of SWRs was also observed in the rTg4510 tauopathy model; here, the reduction of ripples actually preceded the onset of tauopathy and the degradation of place fields (Ciupek et al., 2015). In both Aβ and tauopathy models, the relationship between SWRs and neuronal class appears to vary by neuron type, with excitatory pyramidal neurons more likely to be recruited during SWRs and inhibitory interneurons less likely to fire during SWRs, relative to age-matched controls (Caccavano et al., 2020; Witton et al., 2016). Taken together, these data suggest that features of population activity, such as SWRs, may be better indicators of neuropathology and cognitive dysfunction than the firing patterns of individual neurons. Despite this well-documented association between disruptions in SWR and mouse models of tau and Aβ pathology, the impact of such pathology on phenomena such as replay and preplay is unknown.

6 |. CONCLUSION

The current landscape of AD research is one of scale and approach. Studies at the behavioural level and the molecular and cellular level reflect some of the leading-edge strategies for understanding and treating the disease (Figure 1a, green). At the junction between these approaches in the circuit (Figure 1a, yellow), broadly defined at scales from the synapse and neuron (with complex dendritic topology and principles of synaptic integration) on one end to the connections of groups of cells across multiple brain regions at the other end. As such, there remain numerous outstanding questions in AD research that may inform what cell types and regions are most affected by the cellular pathology as well as how behavioural and cognitive disruptions arise out of changes to circuits and networks in AD.

The framework we have proposed implicitly assumes the translatability of Aβ and tau models. Although the studies of Aβ and tau models described in this review have significantly increased our understanding of AD, several important caveats should be noted (Morris et al., 2014). First, although transgenic models of Aβ pathology have generally expressed forms of APP and presenilin associated with early onset autosomal dominant AD pathogenesis and progression (Goate et al., 1991; Sherrington et al., 1995; Wolfe et al., 1999), most cases of AD in humans are sporadic and not associated with mutations in these genes. Epidemiological studies have revealed certain gene mutations associated with sporadic AD, most notably the ApoE4 allele (Corder et al., 1993; Genin et al., 2011; Jonsson et al., 2012; Morris et al., 2010). Mouse strains incorporating such mutations have been developed (Sullivan et al., 1997, 2004), and as these may model the pathology of human AD more closely than traditional transgenic lines, they represent an important complementary line of investigation. Interestingly, the effect of this pathology across various levels of analysis could provide a parallel avenue for insights into how AD affects circuits. Second, more work needs to be done on the interplay of tau and Aβ, such as the induction and exacerbation of tau pathology by Aβ (Bennett et al., 2017; Bolmont et al., 2007; Lewis et al., 2001). Mouse lines that incorporate both Aβ and tau overexpression, such as the 3xTg strain (Oddo et al., 2003), represent one way to study these complex synergistic effects. Third, it should be acknowledged that Aβ and tau pathology do not occur in a vacuum but rather are imbedded within a rich immunological landscape within the brain (Akiyama et al., 2000; Heneka et al., 2015). Elucidating the role that diverse neuroimmunological cells play in regulating AD associated pathology may reveal how changes in neuronal–non-neuronal interactions percolate across various levels of the neural circuit (Lee & Landreth, 2010; Wang et al., 2015). All three of these caveats represent fertile grounds for inquiry, particularly at the level of circuits and networks.

The changes in the structure of synapses and dendrites and parallel changes in the rules of learning and memory suggest that the picture of single-neuron pathology is multiparametric, a combination of intrinsic properties such as excitability, structural features such as dendritic morphology, and network elements such as the synaptic inputs and the rules by which those synapses change. As a result, it remains unclear if different cell types (e.g., Layer 2/3 pyramidal cells vs. Layer 5 pyramidal cells), which may vary in these features, are equally affected by Aβ and tau. Here, cell ‘identity’ may be defined not only in terms of molecular and cellular features, such as excitatory vs. inhibitory or PV-positive vs. somatostatin-positive, but also in terms of the role that those cells occupy in the network. For example, the hyperactive and hypoactive cells observed in some Aβ and tau models (Busche et al., 2008, 2019) may serve as highly connected network hubs that therefore exert a disproportionate effect on the overall correlated activity of the population. Aβ and tau pathology may also have heterogeneous effects across different brain regions. For example, recent studies show that the functional connectivity across populations of neurons in the dorsal and ventral CA1 region of the hippocampus can be distinct, reflecting differences not only in the underlying architecture of neurons in these areas but also in their dynamics and this coding strategies (Chockanathan & Padmanabhan, 2021). Does Aβ or tau pathology have heterogeneous effects on the networks in these distinct hippocampal subregions? In light of these questions, it is possible that the most successful approaches to understanding and treating AD will focus on restoring network function in parallel with the elimination of Aβ plaques or tau tangles (Adaikkan et al., 2019; Canter et al., 2016; Iaccarino et al., 2016; Martorell et al., 2019).

ACKNOWLEDGEMENTS

K. P. is supported by the National Institute of Child Health and Human Development (NICHD) P50 HD-20-016, National Institute of Mental Health (NIMH) MH113924, and a National Science Foundation (NSF) CAREER award. U. C. is supported by the National Institute of General Medical Sciences (NIGMS) T32 GM007356. We thank two anonymous reviewers for their critical input on this manuscript.

Abbreviations:

AD

Alzheimer’s disease

AMPA

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

APP

amyloid precursor protein

amyloid-β

CA1

cornu Ammonis subfield 1

EEG

electroencephalogram

EPSP

excitatory post-synaptic potential

GABA

gamma-aminobutyric acid

GSK-3β

glycogen synthase kinase-3β

LFP

local field potential

LTD

long-term depression

LTP

long-term potentiation

MRI

magnetic resonance imaging

NMDA

N-methyl-d-aspartate

PACSIN1

protein kinase C and casein kinase substrate in neurons protein 1

PSD-95

post-synaptic density protein 95

PV

parvalbumin

STDP

spike-timing-dependent plasticity

SWR

sharp wave-ripple

Footnotes

CONFLICT OF INTERESTS

The authors declare that they have no conflicts of interest.

DATA AVAILABILITY STATEMENT

No data was generated for this manuscript.

REFERENCES

  1. Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, & Slutsky I (2009). Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses. Nature Neuroscience, 12, 1567–1576. 10.1038/nn.2433 [DOI] [PubMed] [Google Scholar]
  2. Adaikkan C, Middleton SJ, Marco A, Pao PC, Mathys H, Kim DNW, Gao F, Young JZ, Suk HJ, Boyden ES, McHugh TJ, & Tsai LH (2019). Gamma entrainment binds higher-order brain regions and offers neuroprotection. Neuron, 102(5), 929–943.e8. 10.1016/j.neuron.2019.04.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aghajan M, Schuette Z, Fields TA, Tran ME, Siddiqui SM, Hasulak NR, Tcheng TK, Eliashiv D, Mankin EA, Stern J, Fried I, & Suthana N (2017). Theta oscillations in the human medial temporal lobe during real-world ambulatory movement. Current Biology, 27(24), 3743–3751.e3. 10.1016/j.cub.2017.10.062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, & Fiebich BL (2000). Inflammation and Alzheimer’s disease. Neurobiology of Aging, 21, 383–421. 10.1016/S0197-4580(00)00124-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arellano J, Benavides-Piccione R, DeFelipe J, & Yuste R (2007). Ultrastructure of dendritic spines: Correlation between synaptic and spine morphologies. Frontiers in Neuroscience, 1, 131–143. 10.3389/neuro.01.1.1.010.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Aronov D, Nevers R, & Tank DW (2017). Mapping of a non-spatial dimension by the hippocampal–entorhinal circuit. Nature, 543(7647), 719–722. 10.1038/nature21692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bancher C, Braak H, Fischer P, & Jellinger KA (1993). Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer’s and Parkinson’s disease patients. Neuroscience Letters, 162(1–2), 179–182. 10.1016/0304-3940(93)90590-H [DOI] [PubMed] [Google Scholar]
  8. Barbero-Camps E, Fernández A, Baulies A, Martinez L, Fernández-Checa JC, & Colell A (2014). Endoplasmic reticulum stress mediates amyloid β neurotoxicity via mitochondrial cholesterol trafficking. The American Journal of Pathology, 184(7), 2066–2081. 10.1016/j.ajpath.2014.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barlow HB (1972). Single units and sensation: A neuron doctrine for perceptual psychology? Perception, 1, 371–394. 10.1068/p010371 [DOI] [PubMed] [Google Scholar]
  10. Bartos M, Vida I, & Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nature Reviews Neuroscience, 8(1), 45–56. 10.1038/nrn2044 [DOI] [PubMed] [Google Scholar]
  11. Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, Roe AD, Frosch MP, Pitstick R, & Carlson GA (2017). Enhanced tau aggregation in the presence of amyloid β. The American Journal of Pathology, 187, 1601–1612. 10.1016/j.ajpath.2017.03.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bi G, & Poo M (1998). Synaptic modifications in cultured hippocampal neurons: Dependence on spike timing, synaptic strength, and postsynaptic cell type. The Journal of Neuroscience, 18(24), 10464–10472. 10.1523/JNEUROSCI.18-24-10464.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bieri KW, Bobbitt KN, & Colgin LL (2014). Slow and fast gamma rhythms coordinate different spatial coding modes in hippocampal place cells. Neuron, 82(3), 670–681. 10.1016/j.neuron.2014.03.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Biundo F, Del Prete D, Zhang H, Arancio O, & D’Adamio L (2018). A role for tau in learning, memory and synaptic plasticity. Scientific Reports, 8, 3184. 10.1038/s41598-018-21596-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bliss TVP, & Lømo T (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. The Journal of Physiology, 232, 331–356. 10.1113/jphysiol.1973.sp010273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, & Jucker M (2007). Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP × tau transgenic mice. The American Journal of Pathology, 171(6), 2012–2020. 10.2353/ajpath.2007.070403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Booth CA, Witton J, Nowacki J, Tsaneva-Atanasova K, Jones MW, Randall AD, & Brown JT (2016). Altered intrinsic pyramidal neuron properties and pathway-specific synaptic dysfunction underlie aberrant hippocampal network function in a mouse model of tauopathy. The Journal of Neuroscience, 36, 350–363. 10.1523/JNEUROSCI.2151-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Braak H, & Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82(4), 239–259. 10.1007/BF00308809 [DOI] [PubMed] [Google Scholar]
  19. Braak H, Thal DR, Ghebremedhin E, & Del Tredici K (2011). Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. Journal of Neuropathology and Experimental Neurology, 70, 960–969. 10.1097/NEN.0b013e318232a379 [DOI] [PubMed] [Google Scholar]
  20. Bragin A, Jando G, Nadasdy Z, Hetke J, Wise K, & Buzsaki G (1995). Gamma (40–100 Hz) oscillation in the hippocampus of the behaving rat. The Journal of Neuroscience, 15, 47–60. 10.1523/JNEUROSCI.15-01-00047.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TLS, & Ances BM (2016). Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Science Translational Medicine, 8, 338ra66. 10.1126/scitranslmed.aaf2362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, & Konnerth A (2012). Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences, 109(22), 8740–8745. 10.1073/pnas.1206171109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold K, Haass C, Staufenbiel M, Konnerth A, & Garaschuk O (2008). Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science, 321, 1686–1690. [DOI] [PubMed] [Google Scholar]
  24. Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, Kamath T. v., Carlson GA, Nelken I, & Hyman BT (2019). Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. Nature Neuroscience, 22, 57–64. 10.1038/s41593-018-0289-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Buzsáki G (1986). Hippocampal sharp waves: Their origin and significance. Brain Research, 398, 242–252. 10.1016/0006-8993(86)91483-6 [DOI] [PubMed] [Google Scholar]
  26. Buzsáki G, & Vanderwolf CH (1983). Cellular bases of hippocampal EEG in the behaving rat. Brain Research Reviews, 6(2), 139–171. 10.1016/0165-0173(83)90037-1 [DOI] [PubMed] [Google Scholar]
  27. Caccavano A, Bozzelli PL, Forcelli PA, Pak DTS, Wu J-Y, Conant K, & Vicini S (2020). Inhibitory parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial Alzheimer’s disease. The Journal of Neuroscience, 40, 5116–5136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Cacucci F, Yi M, Wills TJ, Chapman P, & O’Keefe J (2008). Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model. Proceedings of the National Academy of Sciences, 105(22), 7863–7868. 10.1073/pnas.0802908105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. y Cajal SR (1911). Histologie Du Système Nerveux de l’homme & Des Vertébrés: Cervelet, Cerveau Moyen, Rétine, Couche Optique, Corps Strié, Écorce Cérébrale Générale & Régionale, Grand Sympathique. A. Maloine. [Google Scholar]
  30. Canter RG, Penney J, & Tsai L-H (2016). The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature, 539(7628), 187–196. 10.1038/nature20412 [DOI] [PubMed] [Google Scholar]
  31. Cardin JA, Carlén M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai L-H, & Moore CI (2009). Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature, 459(7247), 663–667. 10.1038/nature08002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Carlén M, Meletis K, Siegle JH, Cardin JA, Futai K, Vierling-Claassen D, Rühlmann C, Jones SR, Deisseroth K, Sheng M, Moore CI, & Tsai L-H (2012). A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Molecular Psychiatry, 17, 537–548. 10.1038/mp.2011.31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Carrillo-Reid L, Han S, Yang W, Akrouh A, Carrillo-reid L, Han S, Yang W, Akrouh A, & Yuste R (2019). Controlling visually guided behavior by holographic recalling of cortical ensembles. Cell, 178, 447–457.e5. 10.1016/j.cell.2019.05.045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Carrillo-Reid L, Yang W, Bando Y, Peterka DS, & Yuste R (2016). Imprinting and recalling cortical ensembles. Science, 353, 691–694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cash S, & Yuste R (1999). Linear summation of excitatory inputs by CA1 pyramidal neurons. Neuron, 22, 383–394. 10.1016/S0896-6273(00)81098-3 [DOI] [PubMed] [Google Scholar]
  36. Cayzac S, Mons N, Ginguay A, Allinquant B, Jeantet Y, & Cho YH (2015). Altered hippocampal information coding and network synchrony in APP-PS1 mice. Neurobiology of Aging, 36(12), 3200–3213. 10.1016/j.neurobiolaging.2015.08.023 [DOI] [PubMed] [Google Scholar]
  37. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TVP, Hyman BT, Younkin SG, & Hsiao KK (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nature Neuroscience, 2(3), 271–276. 10.1038/6374 [DOI] [PubMed] [Google Scholar]
  38. Chen X, Leischner U, Rochefort NL, Nelken I, & Konnerth A (2011). Functional mapping of single spines in cortical neurons in vivo. Nature, 475, 501–505. 10.1038/nature10193 [DOI] [PubMed] [Google Scholar]
  39. Cheng J, & Ji D (2013). Rigid firing sequences undermine spatial memory codes in a neurodegenerative mouse model. eLife, 2, e00647. 10.7554/eLife.00647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Chockanathan U, & Padmanabhan K (2021). Divergence in population coding for space between dorsal and ventral CA1. Eneuro, 8, ENEURO.0211–21.2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chockanathan U, Warner EJEJ, Turpin L, O’Banion MKK, & Padmanabhan K (2020). Altered dorsal CA1 neuronal population coding in the APP/PS1 mouse model of Alzheimer’s disease. Scientific Reports, 10, 1–12. 10.1038/s41598-020-58038-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ciupek SM, Cheng J, Ali YO, Lu H-C, & Ji D (2015). Progressive functional impairments of hippocampal neurons in a Tauopathy mouse model. The Journal of Neuroscience, 35(21), 8118–8131. 10.1523/JNEUROSCI.3130-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Cloyd RA, Koren J, Abisambra JF, & Smith BN (2021). Effects of altered tau expression on dentate granule cell excitability in mice. Experimental Neurology, 343, 113766. 10.1016/j.expneurol.2021.113766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Cobb SR, Buhl EH, Halasy K, Paulsen O, & Somogyi P (1995). Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature, 378(6552), 75–78. 10.1038/378075a0 [DOI] [PubMed] [Google Scholar]
  45. Concepcion E, Rungnirand P, Hideki V, & Geldmacher DS (2015). Clock drawing test in very mild Alzheimer’s disease. Journal of the American Geriatrics Society, 46, 1266–1269. [DOI] [PubMed] [Google Scholar]
  46. Congdon EE, & Sigurdsson EM (2018). Tau-targeting therapies for Alzheimer disease. Nature Reviews Neurology, 14(7), 399–415. 10.1038/s41582-018-0013-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small G, Roses AD, Haines JL, & Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), 921–923. 10.1126/science.8346443 [DOI] [PubMed] [Google Scholar]
  48. Crimins JL, Pooler A, Polydoro M, Luebke JI, & Spires-Jones TL (2013). The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer’s disease. Ageing Research Reviews, 12, 757–763. 10.1016/j.arr.2013.03.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, & Wolfson L (1988). Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology, 38, 1682. [DOI] [PubMed] [Google Scholar]
  50. Cummings JL, Morstorf T, & Zhong K (2014). Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures. Alzheimer’s Research & Therapy, 6, 37. 10.1186/alzrt269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Deters N, Ittner LM, & Götz J (2008). Divergent phosphorylation pattern of tau in P301L tau transgenic mice. European Journal of Neuroscience, 28, 137–147. 10.1111/j.1460-9568.2008.06318.x [DOI] [PubMed] [Google Scholar]
  52. Di J, Cohen LS, Corbo CP, Phillips GR, El Idrissi A, & Alonso AD (2016). Abnormal tau induces cognitive impairment through two different mechanisms: Synaptic dysfunction and neuronal loss. Scientific Reports, 6, 20833. 10.1038/srep20833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Diba K, & Buzsáki G (2007). Forward and reverse hippocampal place-cell sequences during ripples. Nature Neuroscience, 10, 1241–1242. 10.1038/nn1961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, & Mohs R (2014). Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. New England Journal of Medicine, 370, 311–321. 10.1056/NEJMoa1312889 [DOI] [PubMed] [Google Scholar]
  55. Dragoi G, & Tonegawa S (2011). Preplay of future place cell sequences by hippocampal cellular assemblies. Nature, 469(7330), 397–401. 10.1038/nature09633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Drummond E, & Wisniewski T (2017). Alzheimer’s disease: Experimental models and reality. Acta Neuropathologica, 133, 155–175. 10.1007/s00401-016-1662-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dudman JT, Tsay D, & Siegelbaum SA (2007). A role for synaptic inputs at distal dendrites: Instructive signals for hippocampal long-term plasticity. Neuron, 56, 866–879. 10.1016/j.neuron.2007.10.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Dupret D, O’Neill J, Pleydell-Bouverie B, & Csicsvari J (2010). The reorganization and reactivation of hippocampal maps predict spatial memory performance. Nature Neuroscience, 13(8), 995–1002. 10.1038/nn.2599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Engel AK, Kreiter AK, König P, & Singer W (1991). Synchronization of oscillatory neuronal responses between striate and extrastriate visual cortical areas of the cat. Proceedings of the National Academy of Sciences, 88(14), 6048–6052. 10.1073/pnas.88.14.6048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Engert F, & Bonhoeffer T (1999). Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature, 399(6731), 66–70. 10.1038/19978 [DOI] [PubMed] [Google Scholar]
  61. Fá M, Puzzo D, Piacentini R, Staniszewski A, Zhang H, Baltrons MA, Li Puma DD, Chatterjee I, Li J, Saeed F, Berman HL, Ripoli C, Gulisano W, Gonzalez J, Tian H, Costa JA, Lopez P, Davidowitz E, Yu WH, … Arancio O (2016). Extracellular tau oligomers produce an immediate impairment of LTP and memory. Scientific Reports, 6, 19393. 10.1038/srep19393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, & Siemers ER (2012). Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease. Alzheimer’s & Dementia, 8(4), 261–271. 10.1016/j.jalz.2011.09.224 [DOI] [PubMed] [Google Scholar]
  63. Fitzjohn SM, Kuenzi F, Morton RA, Rosahl TW, Lewis H, Smith D, Seabrook GR, & Collingridge GL (2010). A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1. Molecular Brain, 3, 21. 10.1186/1756-6606-3-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Foster DJ, & Wilson MA (2006). Reverse replay of behavioural sequences in hippocampal place cells during the awake state. Nature, 440(7084), 1–4. 10.1038/nature04587 [DOI] [PubMed] [Google Scholar]
  65. Foster DJ, & Wilson MA (2007). Hippocampal theta sequences. Hippocampus, 17(11), 1093–1099. 10.1002/hipo.20345 [DOI] [PubMed] [Google Scholar]
  66. Fries P (2009). Neuronal gamma-band synchronization as a fundamental process in cortical computation. Annual Review of Neuroscience, 32(1), 209–224. 10.1146/annurev.neuro.051508.135603 [DOI] [PubMed] [Google Scholar]
  67. Froemke RC, & Dan Y (2002). Spike-timing-dependent synaptic modification induced by natural spike trains. Nature, 416(6879), 433–438. 10.1038/416433a [DOI] [PubMed] [Google Scholar]
  68. Froemke RC, Poo M, & Dan Y (2005). Spike-timing-dependent synaptic plasticity depends on dendritic location. Nature, 434(7030), 221–225. 10.1038/nature03366 [DOI] [PubMed] [Google Scholar]
  69. Garad M, Edelmann E, & Leßmann V (2021). Impairment of spike-timing-dependent plasticity at Schaffer collateral-CA1 synapses in adult APP/PS1 mice depends on proximity of Aβ plaques. International Journal of Molecular Sciences, 22(3), 1378. 10.3390/ijms22031378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Gengler S, Hamilton A, & Hölscher C (2010). Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer’s disease is impaired in old but not young mice. PLoS ONE, 5(3), e9764. 10.1371/journal.pone.0009764 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, de Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fiévet N, Brouwers N, Bettens K, Arosio B, Coto E, del Zompo M, … Campion D (2011). APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Molecular Psychiatry, 16, 903–907. 10.1038/mp.2011.52 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Giannakopoulos P, Herrmann FR, Bussière T, Bouras C, Kövari E, Perl DP, Morrison JH, Gold G, & Hof PR (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology, 60, 1495–1500. 10.1212/01.WNL.0000063311.58879.01 [DOI] [PubMed] [Google Scholar]
  73. Gillespie AK, Astudillo Maya DA, Denovellis EL, Liu DF, Kastner DB, Coulter ME, Roumis DK, Eden UT, & Frank LM (2021). Hippocampal replay reflects specific past experiences rather than a plan for subsequent choice. bioRxiv, 109(19), 3149–3163.e6. 10.1016/j.neuron.2021.07.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Gillespie AK, Jones EA, Lin Y-H, Karlsson MP, Kay K, Yoon SY, Tong LM, Nova P, Carr JS, Frank LM, & Huang Y (2016). Apolipoprotein E4 causes age-dependent disruption of slow gamma oscillations during hippocampal sharp-wave ripples. Neuron, 90, 740–751. 10.1016/j.neuron.2016.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Girardeau G, & Zugaro M (2011). Hippocampal ripples and memory consolidation. Current Opinion in Neurobiology, 21(3), 452–459. 10.1016/j.conb.2011.02.005 [DOI] [PubMed] [Google Scholar]
  76. Gjorgjieva J, Drion G, & Marder E (2016). Computational implications of biophysical diversity and multiple timescales in neurons and synapses for circuit performance. Current Opinion in Neurobiology, 37, 44–52. 10.1016/j.conb.2015.12.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, … Hardy J (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature, 349(6311), 704–706. 10.1038/349704a0 [DOI] [PubMed] [Google Scholar]
  78. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, & Hyman BT (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Annals of Neurology, 41, 17–24. 10.1002/ana.410410106 [DOI] [PubMed] [Google Scholar]
  79. Götz J, Chen F, Barmettler R, & Nitsch RM (2001). Tau filament formation in transgenic mice expressing P301L tau. Journal of Biological Chemistry, 276, 529–534. 10.1074/jbc.M006531200 [DOI] [PubMed] [Google Scholar]
  80. Goutagny R, Gu N, Cavanagh C, Jackson J, Chabot J-G, Quirion R, Krantic S, & Williams S (2013). Alterations in hippocampal network oscillations and theta–gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer’s disease. European Journal of Neuroscience, 37(12), 1896–1902. 10.1111/ejn.12233 [DOI] [PubMed] [Google Scholar]
  81. Gray CM (1994). Synchronous oscillations in neuronal systems: Mechanisms and functions. Journal of Computational Neuroscience, 1(1–2), 11–38. 10.1007/BF00962716 [DOI] [PubMed] [Google Scholar]
  82. Gray CM, König P, Engel AK, & Singer W (1989). Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties. Nature, 338(6213), 334–337. 10.1038/338334a0 [DOI] [PubMed] [Google Scholar]
  83. Greene JDW, Baddeley AD, & Hodges JR (1996). Analysis of the episodic memory deficit in early Alzheimer’s disease: Evidence from the doors and people test. Neuropsychologia, 34, 537–551. 10.1016/0028-3932(95)00151-4 [DOI] [PubMed] [Google Scholar]
  84. Grienberger C, Rochefort NL, Adelsberger H, Henning HA, Hill DN, Reichwald J, Staufenbiel M, & Konnerth A (2012). Staged decline of neuronal function in vivo in an animal model of Alzheimer’s disease. Nature Communications, 3, 710–774. 10.1038/ncomms1783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, & Wisniewski HM (1986). Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. Journal of Biological Chemistry, 261(13), 6084–6089. 10.1016/S0021-9258(17)38495-8 [DOI] [PubMed] [Google Scholar]
  86. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, & Binder LI (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences, 83, 4913–4917. 10.1073/pnas.83.13.4913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Guntupalli S, Widagdo J, & Anggono V (2016). Amyloid-β-induced dysregulation of AMPA receptor trafficking. Neural Plasticity, 2016, 3204519. 10.1155/2016/3204519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Gureviciene I, Ikonen S, Gurevicius K, Sarkaki A, van Groen T, Pussinen R, Ylinen A, & Tanila H (2004). Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. Neurobiology of Disease, 15, 188–195. 10.1016/j.nbd.2003.11.011 [DOI] [PubMed] [Google Scholar]
  89. Hafting T, Fyhn M, Molden S, Moser MB, & Moser EI (2005). Microstructure of a spatial map in the entorhinal cortex. Nature, 436(7052), 801–806. 10.1038/nature03721 [DOI] [PubMed] [Google Scholar]
  90. Hájos N, Pálhalmi J, Mann EO, Németh B, Paulsen O, & Freund TF (2004). Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro. The Journal of Neuroscience, 24(41), 9127–9137. 10.1523/JNEUROSCI.2113-04.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Hall AM, Throesch BT, Buckingham SC, Markwardt SJ, Peng Y, Wang Q, Hoffman DA, & Roberson ED (2015). Tau-dependent Kv4. 2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer’s disease. Journal of Neuroscience, 35, 6221–6230. 10.1523/JNEUROSCI.2552-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hardy JA, & Higgins GA (1992). Alzheimer’s disease: The amyloid cascade hypothesis. Science, 256(5054), 184–185. 10.1126/science.1566067 [DOI] [PubMed] [Google Scholar]
  93. Hartline HK (1938). The response of single optic nerve fibers of the vertebrate eye to illumination of the retina. American Journal of Physiology-Legacy Content, 121, 400–415. 10.1152/ajplegacy.1938.121.2.400 [DOI] [Google Scholar]
  94. Harvey CD, Collman F, Dombeck DA, & Tank DW (2009). Intracellular dynamics of hippocampal place cells during virtual navigation. Nature, 461(7266), 941–946. 10.1038/nature08499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Hatch RJ, Wei Y, Xia D, & Götz J (2017). Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathologica, 133(5), 717–730. 10.1007/s00401-017-1674-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Hebb DO (1949). The organization of behavior. A neuropsychological theory. John Wiley & Sons. [Google Scholar]
  97. Heller AS, & Bagot RC (2020). Is hippocampal replay a mechanism for anxiety and depression? JAMA Psychiatry, 77, 431–432. 10.1001/jamapsychiatry.2019.4788 [DOI] [PubMed] [Google Scholar]
  98. Heneka MT, Carson MJ, el Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, & Ransohoff RM (2015). Neuroinflammation in Alzheimer’s disease. The Lancet Neurology, 14, 388–405. 10.1016/S1474-4422(15)70016-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hengen KB, Lambo ME, Van Hooser SD, Katz DB, & Turrigiano GG (2013). Firing rate homeostasis in visual cortex of freely behaving rodents. Neuron, 80, 335–342. 10.1016/j.neuron.2013.08.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan L-L, Ashe KH, & Liao D (2010). Tau mis-localization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68, 1067–1081. 10.1016/j.neuron.2010.11.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Hopfield JJ (1982). Neural networks and physical systems with emergent collective computational abilities. Proceedings of the National Academy of Sciences, 79, 2554–2558. 10.1073/pnas.79.8.2554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, Macharouthu A, O’Brien J, Passmore P, Sheehan B, … Phillips P (2012). Donepezil and memantine for moderate-to-severe Alzheimer’s disease. New England Journal of Medicine, 366(10), 893–903. 10.1056/NEJMoa1106668 [DOI] [PubMed] [Google Scholar]
  103. Hsia AY, Masliah E, McConlogue L, Yu G-Q, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, & Mucke L (1999). Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proceedings of the National Academy of Sciences of the United States of America, 96, 3228–3233. 10.1073/pnas.96.6.3228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, & Malinow R (2006). AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron, 52, 831–843. 10.1016/j.neuron.2006.10.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Hubel DH, & Wiesel TN (1962). Receptive fields, binocular interaction and functional architecture in the cat’s visual cortex. The Journal of Physiology, 160, 106–154. 10.1113/jphysiol.1962.sp006837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, & Abdurrob F (2016). Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature, 540(7632), 230–235. 10.1038/nature20587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, & Hyman BT (1997). Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. The Journal of Neuroscience, 17(18), 7053–7059. 10.1523/JNEUROSCI.17-18-07053.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Jadhav SP, Kemere C, German PW, & Frank LM (2012). Awake hippocampal sharp-wave ripples support spatial memory. Science, 336, 1454–1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, & Borchelt DR (2001). Co-expression of multiple transgenes in mouse CNS: A comparison of strategies. Biomolecular Engineering, 17, 157–165. 10.1016/S1389-0344(01)00067-3 [DOI] [PubMed] [Google Scholar]
  110. Ji D, & Wilson MA (2006). Coordinated memory replay in the visual cortex and hippocampus during sleep. Nature Neuroscience, 10, 100–107. 10.1038/nn1825 [DOI] [PubMed] [Google Scholar]
  111. Jia H, Rochefort NL, Chen X, & Konnerth A (2010). Dendritic organization of sensory input to cortical neurons in vivo. Nature, 464, 1307–1312. [DOI] [PubMed] [Google Scholar]
  112. Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo S-C, Bru-Mercier G, Dickinson B, Scullion S, Sheng M, Collingridge G, & Cho K (2011). Aβ1–42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nature Neuroscience, 14, 545–547. 10.1038/nn.2785 [DOI] [PubMed] [Google Scholar]
  113. Johnston D, & Wu SM-S (1994). Foundations of cellular neurophysiology. MIT Press. [Google Scholar]
  114. Jones EA, Gillespie AK, Yoon SY, Frank LM, & Huang Y (2019). Early hippocampal sharp-wave ripple deficits predict later learning and memory impairments in an Alzheimer’s disease mouse model. Cell Reports, 29(8), 2123–2133.e4. 10.1016/j.celrep.2019.10.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson P. v., Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, … Stefansson K (2012). Variant of TREM2 associated with the risk of Alzheimer’s disease. New England Journal of Medicine, 368, 107–116. 10.1056/NEJMoa1211103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Joo HR, & Frank LM (2018). The hippocampal sharp wave–ripple in memory retrieval for immediate use and consolidation. Nature Reviews Neuroscience, 19(12), 744–757. 10.1038/s41583-018-0077-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Jun H, Bramian A, Soma S, Saito T, Saido TC, & Igarashi KM (2020). Disrupted place cell remapping and impaired grid cells in a knockin model of Alzheimer’s disease. Neuron, 107, 1095–1112.e6. 10.1016/j.neuron.2020.06.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Jung MW, Wiener SI, & McNaughton BL (1994). Comparison of spatial firing characteristics of units in dorsal and ventral hippocampus of the rat. Journal of Neuroscience, 74(12), 7347–7356. 10.1523/JNEUROSCI.14-12-07347.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Jura B, Macrez N, Meyrand P, & Bem T (2019). Deficit in hippocampal ripples does not preclude spatial memory formation in APP/PS1 mice. Scientific Reports, 9, 20129. 10.1038/s41598-019-56582-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt H-P, & van den Bussche H (2005). Cholinesterase inhibitors for patients with Alzheimer’s disease: Systematic review of randomised clinical trials. BMJ, 331(7512), 321–327. 10.1136/bmj.331.7512.321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Kasai H, Fukuda M, Watanabe S, Hayashi-Takagi A, & Noguchi J (2010). Structural dynamics of dendritic spines in memory and cognition. Trends in Neurosciences, 33, 121–129. 10.1016/j.tins.2010.01.001 [DOI] [PubMed] [Google Scholar]
  122. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, & Peck A (1988). Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology, 23, 138–144. 10.1002/ana.410230206 [DOI] [PubMed] [Google Scholar]
  123. Keinath AT, Wang ME, Wann EG, Yuan RK, Dudman JT, & Muzzio IA (2014). Precise spatial coding is preserved along the longitudinal hippocampal axis. Hippocampus, 24(12), 1533–1548. 10.1002/hipo.22333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Kidd M (1963). Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature, 197(4863), 192–193. 10.1038/197192b0 [DOI] [PubMed] [Google Scholar]
  125. Kim MJ, Futai K, Jo J, Hayashi Y, Cho K, & Sheng M (2007). Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95. Neuron, 56(3), 488–502. 10.1016/j.neuron.2007.09.007 [DOI] [PubMed] [Google Scholar]
  126. Kitamura T, Ogawa SK, Roy DS, Okuyama T, Morrissey MD, Smith LM, Redondo RL, & Tonegawa S (2017). Engrams and circuits crucial for systems consolidation of a memory. Science, 356, 73–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Kjelstrup KB, Solstad T, Brun VH, Hafting T, Leutgeb S, Witter MP, Moser EI, & Moser M-B (2008). Finite scale of spatial representation in the hippocampus. Science, 321(5885), 140–143. 10.1126/science.1157086 [DOI] [PubMed] [Google Scholar]
  128. Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, & Rowan MJ (2005). Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo. Nature Medicine, 11, 556–561. 10.1038/nm1234 [DOI] [PubMed] [Google Scholar]
  129. Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, & Hyman BT (1999). Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer’s disease. Proceedings of the National Academy of Sciences, 96, 5274–5279. 10.1073/pnas.96.9.5274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Knudsen EI, & Konishi M (1978). Center-surround organization of auditory receptive fields in the owl. Science, 202(4369), 778–780. 10.1126/science.715444 [DOI] [PubMed] [Google Scholar]
  131. Kosik KS, Joachim CL, & Selkoe DJ (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proceedings of the National Academy of Sciences, 83(11), 4044–4048. 10.1073/pnas.83.11.4044 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Kurudenkandy FR, Zilberter M, Biverstål H, Presto J, Honcharenko D, Strömberg R, Johansson J, Winblad B, & Fisahn A (2014). Amyloid-β-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation. The Journal of Neuroscience, 34, 11416–11425. 10.1523/JNEUROSCI.1195-14.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Larkum ME, Zhu JJ, & Sakmann B (1999). A new cellular mechanism for coupling inputs arriving at different cortical layers. Nature, 398(6725), 338–341. 10.1038/18686 [DOI] [PubMed] [Google Scholar]
  134. Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, & Kayed R (2011). Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Molecular Neurodegeneration, 6, 39. 10.1186/1750-1326-6-39 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Latif-Hernandez A, Sabanov V, Ahmed T, Craessaerts K, Saito T, Saido T, & Balschun D (2020). The two faces of synaptic failure in AppNL-GF knock-in mice. Alzheimer’s Research & Therapy, 12, 100. 10.1186/s13195-020-00667-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Lee CYD, & Landreth GE (2010). The role of microglia in amyloid clearance from the AD brain. Journal of Neural Transmission, 117(8), 949–960. 10.1007/s00702-010-0433-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Leung L, Andrews-Zwilling Y, Yoon SY, Jain S, Ring K, Dai J, Wang MM, Tong L, Walker D, & Huang Y (2012). Apolipoprotein E4 causes age-and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS ONE, 7, e53569. 10.1371/journal.pone.0053569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Lewis J, Dickson DW, Lin W-L, Chisholm L, Corral A, Jones G, Yen S-H, Sahara N, Skipper L, & Yager D (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293(5534), 1487–1491. 10.1126/science.1058189 [DOI] [PubMed] [Google Scholar]
  139. Liu X, Ramirez S, Pang PT, Puryear CB, Govindarajan A, Deisseroth K, & Tonegawa S (2012). Optogenetic stimulation of a hippocampal engram activates fear memory recall. Nature, 484(7394), 381–385. 10.1038/nature11028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Low IIC, Williams AH, Campbell MG, Linderman SW, & Giocomo LM (2021). Dynamic and reversible remapping of network representations in an unchanging environment. Neuron, 109, 2967–2980.e11. 10.1016/j.neuron.2021.07.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Lytton WW, & Sejnowski TJ (1991). Simulations of cortical pyramidal neurons synchronized by inhibitory interneurons. Journal of Neurophysiology, 66(3), 1059–1079. 10.1152/jn.1991.66.3.1059 [DOI] [PubMed] [Google Scholar]
  142. Mably AJ, & Colgin LL (2018). Gamma oscillations in cognitive disorders. Current Opinion in Neurobiology, 52, 182–187. 10.1016/j.conb.2018.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Mably AJ, Gereke BJ, Jones DT, & Colgin LL (2017). Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer’s disease. Hippocampus, 27(4), 378–392. 10.1002/hipo.22697 [DOI] [PubMed] [Google Scholar]
  144. Madison D. v., Malenka RC, & Nicoll RA (1991). Mechanisms underlying long-term potentiation of synaptic transmission. Annual Review of Neuroscience, 14, 379–397. 10.1146/annurev.ne.14.030191.002115 [DOI] [PubMed] [Google Scholar]
  145. Magee JC (2000). Dendritic integration of excitatory synaptic input. Nature Reviews Neuroscience, 1(3), 181–190. 10.1038/35044552 [DOI] [PubMed] [Google Scholar]
  146. Mainen ZF, & Sejnowski TJ (1996). Influence of dendritic structure on firing pattern in model neocortical neurons. Nature, 382(6589), 363–366. 10.1038/382363a0 [DOI] [PubMed] [Google Scholar]
  147. Maingret N, Girardeau G, Todorova R, Goutierre M, & Zugaro M (2016). Hippocampo-cortical coupling mediates memory consolidation during sleep. Nature Neuroscience, 19(7), 959–964. 10.1038/nn.4304 [DOI] [PubMed] [Google Scholar]
  148. Manczak M, & Reddy PH (2013). Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: Implications to synaptic dysfunction and neuronal damage. Journal of Alzheimer’s Disease, 36, 285–295. 10.3233/JAD-130275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Mandelkow E-M, & Mandelkow E (1998). Tau in Alzheimer’s disease. Trends in Cell Biology, 8(11), 425–427. 10.1016/S0962-8924(98)01368-3 [DOI] [PubMed] [Google Scholar]
  150. Markram H, Lübke J, Frotscher M, & Sakmann B (1997). Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science, 275(5297), 213–215. 10.1126/science.275.5297.213 [DOI] [PubMed] [Google Scholar]
  151. Martorell AJ, Paulson AL, Suk H-J, Abdurrob F, Drummond GT, Guan W, Young JZ, Kim DN-W, Kritskiy O, Barker SJ, Mangena V, Prince SM, Brown EN, Chung K, Boyden ES, Singer AC, & Tsai L-H (2019). Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell, 177, 256–271.e22. 10.1016/j.cell.2019.02.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Massoud F, & Léger GC (2011). Pharmacological treatment of Alzheimer disease. The Canadian Journal of Psychiatry, 56(10), 579–588. 10.1177/070674371105601003 [DOI] [PubMed] [Google Scholar]
  153. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, & Beyreuther K (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences, 82(12), 4245–4249. 10.1073/pnas.82.12.4245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. McFarland WL, Teitelbaum H, & Hedges EK (1975). Relationship between hippocampal theta activity and running speed in the rat. Journal of Comparative and Physiological Psychology, 88, 324–328. 10.1037/h0076177 [DOI] [PubMed] [Google Scholar]
  155. McKhann G, Drachman D, Folstein M, Katzman R, Price D, & Stadlan EM (1984). Clinical diagnosis of Alzheimer’s disease. Neurology, 34, 939. [DOI] [PubMed] [Google Scholar]
  156. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, & Phelps CH (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association work-groups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7, 263–269. 10.1016/j.jalz.2011.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. McNaughton BL, Battaglia FP, Jensen O, Moser EI, & Moser MB (2006). Path integration and the neural basis of the ‘cognitive map’. Nature Reviews Neuroscience, 7, 663–678. 10.1038/nrn1932 [DOI] [PubMed] [Google Scholar]
  158. Mega MS, Cummings JL, Fiorello T, & Gornbein J (1996). The spectrum of behavioral changes in Alzheimer’s disease. Neurology, 46, 130–135. 10.1212/WNL.46.1.130 [DOI] [PubMed] [Google Scholar]
  159. Mehta MR, Barnes CA, & McNaughton BL (1997). Experience-dependent, asymmetric expansion of hippocampal place fields. Proceedings of the National Academy of Sciences, 94(16), 8918–8921. 10.1073/pnas.94.16.8918 [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Mehta MR, Lee AK, & Wilson MA (2002). Role of experience and oscillations in transforming a rate code into a temporal code. Nature, 417(6890), 741–746. 10.1038/nature00807 [DOI] [PubMed] [Google Scholar]
  161. Meraz-Ríos MA, Lira-De León KI, Campos-Peña V, De Anda-Hernández MA, & Mena-Lopez R (2010). Tau oligomers and aggregation in Alzheimer’s disease. Journal of Neurochemistry, 112, 1353–1367. 10.1111/j.1471-4159.2009.06511.x [DOI] [PubMed] [Google Scholar]
  162. Merino-Serrais P, Benavides-Piccione R, Blazquez-Llorca L, Kastanauskaite A, Rábano A, Avila J, & DeFelipe J (2013). The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease. Brain, 136, 1913–1928. 10.1093/brain/awt088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Merriam AE, Aronson MK, Gaston P, & Wey S (2018). The psychiatric symptoms of Alzheimer’s disease. Journal of the American Geriatrics Society, 36, 7–22. 10.1111/j.1532-5415.1988.tb03427.x [DOI] [PubMed] [Google Scholar]
  164. Meshulam L, Gauthier JL, Brody CD, Tank DW, & Bialek W (2017). Collective behavior of place and non-place neurons in the hippocampal network. Neuron, 96(5), 1178–1191.e4. 10.1016/j.neuron.2017.10.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Hausser M, Major G, & Stuart GJ (2001). Differential shunting of EPSPs by action potentials. Science, 291(5501), 138–141. 10.1126/science.291.5501.138 [DOI] [PubMed] [Google Scholar]
  166. Hausser M, Spruston N, & Stuart GJ (2000). Diversity and dynamics of dendritic signaling. Science, 290(5492), 739–744. 10.1126/science.290.5492.739 [DOI] [PubMed] [Google Scholar]
  167. Mijalkov M, Volpe G, Fernaud-Espinosa I, DeFelipe J, Pereira JB, & Merino-Serrais P (2021). Dendritic spines are lost in clusters in Alzheimer’s disease. Scientific Reports, 11, 12350. 10.1038/s41598-021-91726-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Morris GP, Clark IA, & Vissel B (2014). Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer’s disease. Acta Neuropathologica Communications, 2, 1–21. 10.1186/s40478-014-0135-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, & Mintun MA (2010). APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology, 67, 122–131. 10.1002/ana.21843 [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Müller-Thomsen L, Borgmann D, Morcinek K, Schröder S, Dengler B, Moser N, Neumaier F, Schneider T, Schröder H, & Huggenberger S (2020). Consequences of hyperphosphorylated tau on the morphology and excitability of hippocampal neurons in aged tau transgenic mice. Neurobiology of Aging, 93, 109–123. 10.1016/j.neurobiolaging.2020.03.007 [DOI] [PubMed] [Google Scholar]
  171. Musiek ES, & Bennett DA (2021). Aducanumab and the “post-amyloid” era of Alzheimer research? Neuron, 109(19), 3045–3047. 10.1016/j.neuron.2021.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Nelson CD, Kim MJ, Hsin H, Chen Y, & Sheng M (2013). Phosphorylation of threonine-19 of PSD-95 by GSK-3β is required for PSD-95 mobilization and long-term depression. The Journal of Neuroscience, 33(29), 12122–12135. 10.1523/JNEUROSCI.0131-13.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Nicole O, Hadzibegovic S, Gajda J, Bontempi B, Bem T, & Meyrand P (2016). Soluble amyloid beta oligomers block the learning-induced increase in hippocampal sharp wave-ripple rate and impair spatial memory formation. Scientific Reports, 6, 22728. 10.1038/srep22728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, & LaFerla FM (2003). Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. Neuron, 39, 409–421. 10.1016/S0896-6273(03)00434-3 [DOI] [PubMed] [Google Scholar]
  175. O’Donnell C, Nolan MF, & van Rossum MCW (2011). Dendritic spine dynamics regulate the long-term stability of synaptic plasticity. The Journal of Neuroscience, 31(45), 16142–16156. 10.1523/JNEUROSCI.2520-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. O’Keefe J, & Dostrovsky J (1971). The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Research, 34, 171–175. 10.1016/0006-8993(71)90358-1 [DOI] [PubMed] [Google Scholar]
  177. O’Keefe J, & Nadel L (1978). The hippocampus as a cognitive map. Oxford University Press. [Google Scholar]
  178. O’Keefe J, & Recce ML (1993). Phase relationship between hippocampal place units and the EEG theta rhythm. Hippocampus, 3, 317–330. 10.1002/hipo.450030307 [DOI] [PubMed] [Google Scholar]
  179. Okuyama T, Kitamura T, Roy DS, Itohara S, & Tonegawa S (2016). Ventral CA1 neurons store social memory. Science, 353(6307), 1536–1541. 10.1126/science.aaf7003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Packer AM, Russell LE, Dalgleish HWP, & Häusser M (2015). Simultaneous all-optical manipulation and recording of neural circuit activity with cellular resolution in vivo. Nature Methods, 12, 140–146. 10.1038/nmeth.3217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Padmanabhan K, & Urban NN (2010). Intrinsic biophysical diversity decorrelates neuronal firing while increasing information content. Nature Neuroscience, 13, 1276–1282. 10.1038/nn.2630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, & Mucke L (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron, 55, 697–711. 10.1016/j.neuron.2007.07.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Palop JJ, & Mucke L (2010). Amyloid-B-induced neuronal dysfunction in Alzheimer’s disease: From synapses toward neural networks. Nature Neuroscience, 13(7), 812–818. 10.1038/nn.2583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Palop JJ, & Mucke L (2016). Network abnormalities and interneuron dysfunction in Alzheimer disease. Nature Reviews Neuroscience, 17(12), 777–792. 10.1038/nrn.2016.141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Fries P, Reynolds JH, Rorie AE, & Desimone R (2001). Modulation of oscillatory neuronal synchronization by selective visual attention. Science, 291(5508), 1560–1563. 10.1126/science.1055465 [DOI] [PubMed] [Google Scholar]
  186. Pesaran B, Pezaris JS, Sahani M, Mitra PP, & Andersen RA (2002). Temporal structure in neuronal activity during working memory in macaque parietal cortex. Nature Neuroscience, 5, 805–811. 10.1038/nn890 [DOI] [PubMed] [Google Scholar]
  187. Pfeiffer BE, & Foster DJ (2013). Hippocampal place-cell sequences depict future paths to remembered goals. Nature, 497(7447), 74–81. 10.1038/nature12112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, Staufenbiel M, & Jucker M (1999). Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. Journal of Neuroscience, 19, 8552–8559. 10.1523/JNEUROSCI.19-19-08552.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Poirazi P, Brannon T, & Mel BW (2003). Arithmetic of subthreshold synaptic summation in a model CA1 pyramidal cell. Neuron, 37(6), 977–987. 10.1016/S0896-6273(03)00148-X [DOI] [PubMed] [Google Scholar]
  190. Price JL, & Morris JC (1999). Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Annals of Neurology, 45, 358–368. [DOI] [PubMed] [Google Scholar]
  191. Prince SM, Paulson AL, Jeong N, Zhang L, Amigues S, & Singer AC (2021). Alzheimer’s pathology causes impaired inhibitory connections and reactivation of spatial codes during spatial navigation. Cell Reports, 35, 109008. 10.1016/j.celrep.2021.109008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Puzzo D, Piacentini R, Fá M, Gulisano W, Li Puma DD, Staniszewski A, Zhang H, Tropea MR, Cocco S, Palmeri A, Fraser P, D’Adamio L, Grassi C, & Arancio O (2017). LTP and memory impairment caused by extracellular Aβ and tau oligomers is APP-dependent. eLife, 6, e26991. 10.7554/eLife.26991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Quiroga RQ, Reddy L, Kreiman G, Koch C, & Fried I (2005). Invariant visual representation by single neurons in the human brain. Nature, 435(7045), 1102–1107. 10.1038/nature03687 [DOI] [PubMed] [Google Scholar]
  194. Ram D, R.J L, G.Y E, & H.E.L F (2008). Differential regulation of dynein and kinesin motor proteins by tau. Science, 319(5866), 1086–1089. 10.1126/science.1152993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, & Ashe KH (2005). Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). The Journal of Neuroscience, 25(46), 10637–10647. 10.1523/JNEUROSCI.3279-05.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Regan P, Mitchell SJ, Kim S-C, Lee Y, Yi JH, Barbati SA, Shaw C, & Cho K (2021). Regulation of synapse weakening through interactions of the microtubule associated protein tau with PACSIN1. Journal of Neuroscience, 41(34), 7162–7170. 10.1523/JNEUROSCI.3129-20.2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Regan P, Whitcomb DJ, & Cho K (2017). Physiological and pathophysiological implications of synaptic tau. The Neuroscientist, 23, 137–151. 10.1177/1073858416633439 [DOI] [PubMed] [Google Scholar]
  198. Rickgauer JP, Deisseroth K, & Tank DW (2014). Simultaneous cellular-resolution optical perturbation and imaging of place cell firing fields. Nature Neuroscience, 17(12), 1816–1824. 10.1038/nn.3866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, de LIano SRM, Liu E, Koller M, Gregg KM, Schenk D, Black R, & Grundman M (2010). 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study. The Lancet Neurology, 9(4), 363–372. 10.1016/S1474-4422(10)70043-0 [DOI] [PubMed] [Google Scholar]
  200. Rivas J, Gaztelu JM, & García-Austt E (1996). Changes in hippocampal cell discharge patterns and theta rhythm spectral properties as a function of walking velocity in the guinea pig. Experimental Brain Research, 108, 113–118. 10.1007/BF00242908 [DOI] [PubMed] [Google Scholar]
  201. Roy DS, Arons A, Mitchell TI, Pignatelli M, Ryan TJ, & Tonegawa S (2016). Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease. Nature, 531(7595), 508–512. 10.1038/nature17172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, & Saido TC (2014). Single App knockin mouse models of Alzheimer’s disease. Nature Neuroscience, 17(5), 661–663. 10.1038/nn.3697 [DOI] [PubMed] [Google Scholar]
  203. Saito T, Matsuba Y, Yamazaki N, Hashimoto S, & Saido TC (2016). Calpain activation in Alzheimer’s model mice is an artifact of APP and presenilin overexpression. Journal of Neuroscience, 36(38), 9933–9936. 10.1523/JNEUROSCI.1907-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, … Brashear HR (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. New England Journal of Medicine, 370, 322–333. 10.1056/NEJMoa1304839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, & Roses AD (1994). Apolipoprotein E associates with beta amyloid peptide of Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. The Journal of Clinical Investigation, 94(2), 860–869. 10.1172/JCI117407 [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. SantaCruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, & Ashe KH (2005). Tau suppression in a neurodegenerative mouse model improves memory function. Science, 309(5733), 476–481. 10.1126/science.1113694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, de Strooper B, Hardy J, Vassar R, Winblad B, & Saido TC (2017). APP mouse models for Alzheimer’s disease preclinical studies. The EMBO Journal, 36, 2473–2487. 10.15252/embj.201797397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  208. Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, & Brayne C (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry, 194(3), 212–219. 10.1192/bjp.bp.108.049619 [DOI] [PubMed] [Google Scholar]
  209. Scholl B, Thomas CI, Ryan MA, Kamasawa N, & Fitzpatrick D (2021). Cortical response selectivity derives from strength in numbers of synapses. Nature, 590(7844), 111–114. 10.1038/s41586-020-03044-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  210. Scholl B, Wilson DE, & Fitzpatrick D (2017). Local order within global disorder: Synaptic architecture of visual space. Neuron, 96(5), 1127–1138.e4. 10.1016/j.neuron.2017.10.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Schulz DJ, Goaillard J-M, & Marder E (2006). Variable channel expression in identified single and electrically coupled neurons in different animals. Nature Neuroscience, 9, 356–362. 10.1038/nn1639 [DOI] [PubMed] [Google Scholar]
  212. Schummers J, Mariño J, & Sur M (2002). Synaptic integration by V1 neurons depends on location within the orientation map. Neuron, 36(5), 969–978. 10.1016/S0896-6273(02)01012-7 [DOI] [PubMed] [Google Scholar]
  213. Scott L, Feng J, Kiss T, Needle E, Atchison K, Kawabe TT, Milici AJ, Hajós-Korcsok É, Riddell D, & Hajos M (2012). Age-dependent disruption in hippocampal theta oscillation in amyloid-β overproducing transgenic mice. Neurobiology of Aging, 33(7), 13–23. 10.1016/j.neurobiolaging.2011.12.010 [DOI] [PubMed] [Google Scholar]
  214. Selkoe DJ (1991). The molecular pathology of Alzheimer’s disease. Neuron, 6, 487–498. 10.1016/0896-6273(91)90052-2 [DOI] [PubMed] [Google Scholar]
  215. Selkoe DJ (1994). Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer’s disease. Annual Review of Cell Biology, 10, 373–403. 10.1146/annurev.cb.10.110194.002105 [DOI] [PubMed] [Google Scholar]
  216. Selkoe DJ (2002). Alzheimer’s disease is a synaptic failure. Science, 298, 789–791. [DOI] [PubMed] [Google Scholar]
  217. Serby M, Larson P, & Kalkstein D (1991). The nature and course of olfactory deficits in Alzheimer’s disease. The American Journal of Psychiatry, 148, 357–360. 10.1176/ajp.148.3.357 [DOI] [PubMed] [Google Scholar]
  218. Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O’Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, … Sandrock A (2016). The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature, 537(7618), 50–56. 10.1038/nature19323 [DOI] [PubMed] [Google Scholar]
  219. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, & Selkoe DJ (2008). Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nature Medicine, 14, 837–842. 10.1038/nm1782 [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Sheintuch L, Geva N, Baumer H, Rechavi Y, Rubin A, & Ziv Y (2020). Multiple maps of the same spatial context can stably coexist in the mouse hippocampus. Current Biology, 30(8), 1467–1476.e6. 10.1016/j.cub.2020.02.018 [DOI] [PubMed] [Google Scholar]
  221. Sherrington C (1952). The integrative action of the nervous system. CUP Archive. [Google Scholar]
  222. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, … St George-Hyslop PH (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature, 375(6534), 754–760. 10.1038/375754a0 [DOI] [PubMed] [Google Scholar]
  223. Shipton OA, Leitz JR, Dworzak J, Acton CEJ, Tunbridge EM, Denk F, Dawson HN, Vitek MP, Wade-Martins R, Paulsen O, & Vargas-Caballero M (2011). Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation. The Journal of Neuroscience, 31(5), 1688–1692. 10.1523/JNEUROSCI.2610-10.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Siemers ER, Friedrich S, Dean RA, Gonzales CR, Farlow MR, Paul SM, & DeMattos RB (2010). Safety and changes in plasma and cerebrospinal fluid amyloid β after a single administration of an amyloid β monoclonal antibody in subjects with Alzheimer disease. Clinical Neuropharmacology, 33, 67–73. 10.1097/WNF.0b013e3181cb577a [DOI] [PubMed] [Google Scholar]
  225. Šišková Z, Justus D, Kaneko H, Friedrichs D, Henneberg N, Beutel T, Pitsch J, Schoch S, Becker A, vonderKammer H, & Remy S (2014). Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer’s disease. Neuron, 84(5), 1023–1033. 10.1016/j.neuron.2014.10.024 [DOI] [PubMed] [Google Scholar]
  226. Sjöström PJ, & Nelson SB (2002). Spike timing, calcium signals and synaptic plasticity. Current Opinion in Neurobiology, 12, 305–314. 10.1016/S0959-4388(02)00325-2 [DOI] [PubMed] [Google Scholar]
  227. Sjöström PJ, Turrigiano GG, & Nelson SB (2001). Rate, timing, and cooperativity jointly determine cortical synaptic plasticity. Neuron, 32, 1149–1164. 10.1016/S0896-6273(01)00542-6 [DOI] [PubMed] [Google Scholar]
  228. Skaggs WE, McNaughton BL, & Gothard KM (1993). An information-theoretic approach to deciphering the hippocampal code. Advances in neural information processing systems, 1030–1037. [Google Scholar]
  229. Skaggs WE, McNaughton BL, Wilson MA, & Barnes CA (1996). Theta phase precession in hippocampal neuronal populations and the compression of temporal sequences. Hippocampus, 6, 149–172. [DOI] [PubMed] [Google Scholar]
  230. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, & Greengard P (2005). Regulation of NMDA receptor trafficking by amyloid-β. Nature Neuroscience, 8, 1051–1058. 10.1038/nn1503 [DOI] [PubMed] [Google Scholar]
  231. Sohal VS, Zhang F, Yizhar O, & Deisseroth K (2009). Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature, 459(7247), 698–702. 10.1038/nature07991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Stefanini F, Kushnir L, Jimenez JC, Jennings JH, Woods NI, Stuber GD, Kheirbek MA, Hen R, & Fusi S (2020). A distributed neural code in the dentate gyrus and in CA1. Neuron, 107, 703–716.e4. 10.1016/j.neuron.2020.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Steve R, Xu L, Pei-Ann L, Junghyup S, Michele P, R.R L, R. T J, & Susumu T (2013). Creating a false memory in the hippocampus. Science, 341(6144), 387–391. 10.1126/science.1239073 [DOI] [PubMed] [Google Scholar]
  234. Sullivan PM, Mace BE, Maeda N, & Schmechel D (2004). Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience, 124, 725–733. 10.1016/j.neuroscience.2003.10.011 [DOI] [PubMed] [Google Scholar]
  235. Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, & Maeda N (1997). Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. Journal of Biological Chemistry, 272(29), 17972–17980. 10.1074/jbc.272.29.17972 [DOI] [PubMed] [Google Scholar]
  236. Svoboda K, Helmchen F, Denk W, & Tank DW (1999). Spread of dendritic excitation in layer 2/3 pyramidal neurons in rat barrel cortex in vivo. Nature Neuroscience, 2, 65–73. 10.1038/4569 [DOI] [PubMed] [Google Scholar]
  237. Sydow A, Van der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O, Drexler D, Zhou L, Rune G, Mandelkow E, D’Hooge R, Alzheimer C, & Mandelkow E-M (2011). Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant. The Journal of Neuroscience, 31, 2511–2525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  238. Takamura R, Mizuta K, Sekine Y, Islam T, Saito T, Sato M, Ohkura M, Nakai J, Ohshima T, & Saido TC (2021). Modality-specific impairment of hippocampal CA1 neurons of Alzheimer’s disease model mice. Journal of Neuroscience, 41(24), 5315–5329. 10.1523/JNEUROSCI.0208-21.2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, & Group, for the M.S. (2004). Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial. JAMA, 291, 317–324. 10.1001/jama.291.3.317 [DOI] [PubMed] [Google Scholar]
  240. Teri L, Ferretti LE, Gibbons LE, Logsdon RG, McCurry SM, Kukull WA, McCormick WC, Bowen JD, & Larson EB (1999). Anxiety in Alzheimer’s disease: Prevalence and comorbidity. The Journals of Gerontology: Series A, 54(7), M348–M352. 10.1093/gerona/54.7.M348 [DOI] [PubMed] [Google Scholar]
  241. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, & Katzman R (1991). Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30(4), 572–580. 10.1002/ana.410300410 [DOI] [PubMed] [Google Scholar]
  242. Thal DR, Holzer M, Rüb U, Waldmann G, Günzel S, Zedlick D, & Schober R (2000). Alzheimer-related τ-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Experimental Neurology, 163, 98–110. 10.1006/exnr.2000.7380 [DOI] [PubMed] [Google Scholar]
  243. Thal DR, Rüb U, Orantes M, & Braak H (2002). Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology, 58(12), 1791–1800. 10.1212/WNL.58.12.1791 [DOI] [PubMed] [Google Scholar]
  244. Thal DR, Rüb U, Schultz C, Sassin I, Ghebremedhin E, del Tredici K, Braak E, & Braak H (2000). Sequence of Aβ-protein deposition in the human medial temporal lobe. Journal of Neuropathology & Experimental Neurology, 59, 733–748. 10.1093/jnen/59.8.733 [DOI] [PubMed] [Google Scholar]
  245. Tomlinson BE, Blessed G, & Roth M (1968). Observations on the brains of non-demented old people. Journal of the Neurological Sciences, 7(2), 331–356. 10.1016/0022-510X(68)90154-8 [DOI] [PubMed] [Google Scholar]
  246. Traub RD, Whittington MA, Stanford IM, & Jefferys JGR (1996). A mechanism for generation of long-range synchronous fast oscillations in the cortex. Nature, 383(6601), 621–624. 10.1038/383621a0 [DOI] [PubMed] [Google Scholar]
  247. Tsai J, Grutzendler J, Duff K, & Gan W-B (2004). Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neuroscience, 7, 1181–1183. 10.1038/nn1335 [DOI] [PubMed] [Google Scholar]
  248. Turrigiano GG (2008). The self-tuning neuron: Synaptic scaling of excitatory synapses. Cell, 135, 422–435. 10.1016/j.cell.2008.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, & Nelson SB (1998). Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature, 391(6670), 892–896. 10.1038/36103 [DOI] [PubMed] [Google Scholar]
  250. Vanderwolf CH (1969). Hippocampal electrical activity and voluntary movement in the rat. Electroencephalography and Clinical Neurophysiology, 26, 407–418. 10.1016/0013-4694(69)90092-3 [DOI] [PubMed] [Google Scholar]
  251. Varga Z, Jia H, Sakmann B, & Konnerth A (2011). Dendritic coding of multiple sensory inputs in single cortical neurons in vivo. Proceedings of the National Academy of Sciences, 108(37), 15420–15425. 10.1073/pnas.1112355108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Vershinin M, Carter BC, Razafsky DS, King SJ, & Gross SP (2007). Multiple-motor based transport and its regulation by tau. Proceedings of the National Academy of Sciences, 104, 87–92. 10.1073/pnas.0607919104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Vogel JW, Young AL, Oxtoby NP, Smith R, Ossenkoppele R, Strandberg OT, La Joie R, Aksman LM, Grothe MJ, Iturria-Medina Y, the Alzheimer’s Disease Neuroimaging Initiative, Pontecorvo MJ, Devous MD, Rabinovici GD, Alexander DC, Lyoo CH, Evans AC, & Hansson O (2021). Four distinct trajectories of tau deposition identified in Alzheimer’s disease. Nature Medicine, 27, 871–881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. Vogt BA, Crino PB, & Vogt LJ (1992). Reorganization of cingulate cortex in Alzheimer’s disease: Neuron loss, neuritic plaques, and muscarinic receptor binding. Cerebral Cortex, 2, 526–535. 10.1093/cercor/2.6.526 [DOI] [PubMed] [Google Scholar]
  255. Volgushev M, Pernberg J, & Eysel UT (2000). Comparison of the selectivity of postsynaptic potentials and spike responses in cat visual cortex. European Journal of Neuroscience, 12, 257–263. 10.1046/j.1460-9568.2000.00909.x [DOI] [PubMed] [Google Scholar]
  256. Wang J-Z, Grundke-Iqbal I, & Iqbal K (1996). Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer’s disease. Nature Medicine, 2, 871–875. 10.1038/nm0896-871 [DOI] [PubMed] [Google Scholar]
  257. Wang W-Y, Tan M-S, Yu J-T, & Tan L (2015). Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Annals of Translational Medicine, 3(10), 136–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Warner MD, Peabody CA, Flattery JJ, & Tinklenberg JR (1986). Olfactory deficits and Alzheimer’s disease. Biological Psychiatry, 21, 116–118. 10.1016/0006-3223(86)90013-2 [DOI] [PubMed] [Google Scholar]
  259. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, & Malinow R (2009). Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nature Neuroscience, 13, 190–196. 10.1038/nn.2476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Weingarten MD, Lockwood AH, Hwo SY, & Kirschner MW (1975). A protein factor essential for microtubule assembly. Proceedings of the National Academy of Sciences, 72, 1858–1862. 10.1073/pnas.72.5.1858 [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. West MJ, Coleman PD, Flood DG, & Troncoso JC (1994). Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. The Lancet, 344(8925), 769–772. 10.1016/S0140-6736(94)92338-8 [DOI] [PubMed] [Google Scholar]
  262. Whitesell JD, Buckley AR, Knox JE, Kuan L, Graddis N, Pelos A, Mukora A, Wakeman W, Bohn P, & Ho A (2018). Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer’s disease. Journal of Comparative Neurology, 527(13), 2122–2145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Whittington MA, Traub RD, & Jefferys JGR (1995). Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature, 373(6515), 612–615. 10.1038/373612a0 [DOI] [PubMed] [Google Scholar]
  264. Wilson DE, Scholl B, & Fitzpatrick D (2018). Differential tuning of excitation and inhibition shapes direction selectivity in ferret visual cortex. Nature, 560(7716), 97–101. 10.1038/s41586-018-0354-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Wilson DE, Whitney DE, Scholl B, & Fitzpatrick D (2016). Orientation selectivity and the functional clustering of synaptic inputs in primary visual cortex. Nature Neuroscience, 19(8), 1003–1009. 10.1038/nn.4323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Wilson MA, & McNaughton BL (1993). Dynamics of the hippocampal ensemble code for space. Science, 261, 1055–1058. [DOI] [PubMed] [Google Scholar]
  267. Witton J, Staniaszek LE, Bartsch U, Randall AD, Jones MW, & Brown JT (2016). Disrupted hippocampal sharp-wave ripple-associated spike dynamics in a transgenic mouse model of dementia. The Journal of Physiology, 594, 4615–4630. 10.1113/jphysiol.2014.282889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  268. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, & Selkoe DJ (1999). Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature, 398(6727), 513–517. 10.1038/19077 [DOI] [PubMed] [Google Scholar]
  269. Yoshiyama Y, Higuchi M, Zhang B, Huang S-M, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, & Lee VM-Y (2007). Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron, 53, 337–351. 10.1016/j.neuron.2007.01.010 [DOI] [PubMed] [Google Scholar]
  270. Yuste R, & Bonhoeffer T (2001). Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annual Review of Neuroscience, 24, 1071–1089. 10.1146/annurev.neuro.24.1.1071 [DOI] [PubMed] [Google Scholar]
  271. Zheng C, Bieri KW, Hsiao Y-T, & Colgin LL (2016). Spatial sequence coding differs during slow and fast gamma rhythms in the hippocampus. Neuron, 89, 398–408. 10.1016/j.neuron.2015.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Zheng C, Bieri KW, Hwaun E, & Colgin LL (2016). Fast gamma rhythms in the hippocampus promote encoding of novel object–place pairings. Eneuro, 3, ENEURO.0001–16.2016. 10.1523/ENEURO.0001-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Ziv Y, Burns LD, Cocker ED, Hamel EO, Ghosh KK, Kitch LJ, El Gamal A, & Schnitzer MJ (2013). Long-term dynamics of CA1 hippocampal place codes. Nature Neuroscience, 16, 264–266. 10.1038/nn.3329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Zuo Y, Lin A, Chang P, & Gan W-B (2005). Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron, 46, 181–189. 10.1016/j.neuron.2005.04.001 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No data was generated for this manuscript.

RESOURCES